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 β‐N‐methylamino‐L‐alanine BuOH 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C 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D 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ionisation F (Phe)  Phenylalanine FAIMS  Field‐asymmetric waveform ion mobility mass spectrometry FT   Fourier transform FT‐ICR‐MS  Fourier transform ion cyclotron resonance mass spectrometer FWHM   Full width at half maximum G (Gly)  Glycine GC  Gas chromatography hI  Homoisoleucine HOAc  Acetic acid HPLC   High‐performance liquid chromatography hR  Homoarginine IC50    Compound concentration that gives 50% inhibition on enzyme activity I.D.  Inner diameter (of an HPLC column) IM‐MS  Ion mobility‐mass spectrometry L (Leu)   Leucine LC   Liquid chromatography LC‐MS   Liquid chromatography – mass spectrometry LD50  Dose that is lethal to 50% of the test animals LOD  Limit of detection LOQ  Limit of quantitation M (Met)  Methionine MALDI   Matrix‐assisted laser desorption/ionisation MC   Microcystin MC‐LR eq/l  Microcystin‐LR equivalents / liter (used in UV‐HPLC detection) Mdha   N‐methyldehydroalanine MeOH  Methanol MMPB   2‐methyl‐3‐methoxy‐4‐phenylbutyric acid 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MS   Mass spectrometry MS‐MS   Tandem mass spectrometry  MSn  Sequential mass spectrometry fragmentations (n rounds) MRM/ SRM  Multiple reactant monitoring/ Single reactant monitoring 
m/z   Mass to charge ratio NMeSer  N‐methylserine Nod   Nodularin P (Phe)   Phenylalanine PP  Protein phosphatase PPIA   Protein phosphatase inhibiton assay Q   Quadrupole mass analyser (filter) QQQ   Triple quadrupole mass analyser R (Arg)   Arginine RF   Radio frequency RP  Reversed‐phase Rs  Resolution S (Ser)  Serine SIM/ SIR  Single ion monitoring/ single ion recording SPE   Solid‐phase extraction S/N  Signal to noise –ratio TOF  Time‐of‐flight UHPLC  Ultra high‐performance liquid chromatography UPLC  Waters Corporation’s registered trademark for Ultra‐Performance Liquid Chromatography UV  Ultraviolet V (Val)   Valine W (Trp)   Tryptophan Y (Tyr)  Tyrosine Å   Ångström (10‐10 m, 0.1 nm) 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1. Introduction and review of the literature  Liquid chromatography – mass spectrometry  Liquid chromatography ‐ mass spectrometry (LC‐MS) is a powerful analytical tool. It is based on the separation of compounds of interest by high‐performance liquid chromatography,  ionisation  of  the  sample  analytes  in  an  ionisation  source,  and analyte detection by mass spectrometry. Mass spectrometer is a very universal, or generic, detection method, but still a highly selective one. The  current  applications  for  LC‐MS  vary  from  purely  chemical  analysis  of  small molecules, such as reaction and synthesis products and drug molecules to analysis of  different  types  of  biological  macromolecules.  The  instrumentation  is  used  in elemental  analysis,  petrol  and  pharmaceutical  industry,  food  safety  analysis, clinical  diagnostics,  environmental  analysis  and  in  analysis  of  biological  systems with applications such as proteomics and metabolomics, etc.   
  Figure 1.1 Schematic  presentation of  a  LC‐ESI‐MS‐MS  instrumentation.  The HPLC parts  include  the mobile  phase  reservoirs,  degasser,  pump  with  mixing  chamber,  automatic  sampling system (autosampler) and analytical column in a thermostated column oven. The column is usually packed with spherical porous silica particles that have been covered, or bonded with  the  stationary  phase  material  (e.g.  reversed‐phase  C‐18  material).  The  flow  from analytical column  is  then directed to  the  ionisation source (electrospray) of  the detector MS  (e.g.  a  triple  quadrupole) where  the  separated  analytes  give  rise  to  signals  that  are recorded and later on processed with data‐analysis software. 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The general concept of  liquid chromatography ‐ mass spectrometry  is separation of compounds based on different physico‐chemical properties and detection based on ionic mass of the analytes. The wide applicability brings together experts from different  fields,  such  as  physics,  chemistry,  engineering,  biology,  medicine, pharmacy,  etc.  The  field  of  mass  spectrometry  is  highly  dynamic,  as  it  is continuously  driven  forward  by  different  developments  from  different  fields  of science to improve various applications. The  current  trend  is  instrumentation  to meet  the  requirements  of  higher  speed (higher  throughput) without  compromising on sensitivity,  accuracy and stability. Also data‐analysis software has been improved for more efficient data‐mining.   1.1. High‐performance liquid chromatography  High‐performance liquid chromatography (HPLC) separates compounds based on the interaction and physico‐chemical preference of the analyte between stationary phase and mobile phase. The analytes are driven further within the column packed with particles with the help  of  liquid  mobile  phase,  which  is  pumped  through  the  column  with  high pressure.  The  compounds  interacting  more  strongly  with  the  stationary  phase than  with  the  mobile  phase  will  be  retained  in  the  column  for  longer.  The interaction  between  the  stationary  phase  and  the  analyte  is  determined  by  the material  the  porous  particles  are  covered with,  called  bonded  phase,  as  well  as with the properties of the mobile phase. The stationary phase can be hydrophilic (e.g.  silica  surface  in  normal  phase  chromatography  with  increasing  gradient  of polar  solvent  in  the  mobile  phase)  or  hydrophobic  (reversed‐phase chromatography with increasing gradient of organic solvent in the mobile phase). More  specifically,  the  bonded  phase  material  can  be  alkene  chains  of  different length,  chains  of  carbon  and  heteroatoms,  specific  interacting  groups  (phenyl rings, chiral residues etc.), ion exchange material etc. [1].   Recent developments  in HPLC aim at  faster separation and better sensitivity and include  higher‐pressure  pumps  (called  ultra  high‐performance  liquid chromatography, UHPLC or UPLC) [2‐5] that allow the use of small particle size (2 µm or less in diameter) columns with high flow rates. Earlier the typical pressure limit  for  a  HPLC  system  was  around  400  bars,  whereas  now  the  limit  in instruments  provided  by  many  different  manufacturers  (such  as  Waters  Ultra‐Performance Liquid Chromatography system) is around 1000 bars.  HPLC  instrumentation  consists  of mobile  phase  reservoirs,  pump  (with  gradient mixer),  autosampler  with  injector,  thermostated  column  compartment,  an analytical column and detector (see figure 1.1). All of these different parts need to be connected  for  the mobile phase  flow, and create the total system volume. The current  developments  aim  for  reduced  total  system volume  and higher‐pressure tolerance to obtain faster and more sensitive analysis methods.  Also  the  autosamplers  for  sample  injection  have  become  faster  and  the  dead volumes  inside  the  pumps  have  been  decreased  into  µl  range.  All  of  these improvements aim for faster throughput and higher efficiency. The  recent  developments  have  improved  the  throughput,  the  separation  and therefore  resulted  in  faster  and more  sensitive  analysis  enabling  the  analysis  of complex sample within a single run [4].
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The  separated  analytes  can  be  detected  by  different  means,  for  example  by fluorescence,  (UV‐)  light  absorption,  light  scattering,  electric  conductivity  or  by mass  spectrometry.  With  UV‐detection,  the  absorbance  can  be  specified  to  a certain wavelength, depending on the absorbance spectra of the analyte of interest. This  detection method  therefore  gives  two  levels  of  information,  retention  time and absorbance at a specified wavelength. Further verification can be obtained by inspecting the absorbance spectra obtained by a diode array detector (DAD).   1.1.1. Different modes of separation and the effect of particle and pore size  HPLC  can  be  operated  on  several  different  modes  of  separation:  in  addition  to normal and reversed‐phase chromatography,  there are  ion exchange, hydrophilic interaction,  chiral,  aromatic  (π‐π)  interaction,  other  specific  functional  group interactions, but also size exclusion and immunoaffinity separation modes [1]. The method  for  separation  is  therefore  very  versatile.  In  general,  one  aims  for well‐resolved and narrow HPLC peaks with high signal response.  Van Deemter equation   H = A + (B/u)+ (Cu)  H  =  HETP  (Height  equivalent  of  theoretical  plates)  (The  lower  value  indicates higher efficiency) 
u = Mobile phase linear velocity  A, B, and C are constants which account for contributions to band broadening A = Eddy diffusion term (e.g. directly proportional  to the particle size, due to the presence of stationary phase particles and therefore different flow channels/ paths for the molecules) B = Longitudinal diffusion term (depending on viscosity etc. of the mobile phase) C = Resistance to mass transfer coefficient (takes into account the diffusion in the mobile phase and in the stationary phase. Affected by parameters such as particle size, mobile phase viscosity and temperature)  The van Deemter equation states that with particle size below 2 µm the efficiency does not significantly diminish with higher flow rates [6]. The smaller particle size allows  tighter packing of  the  columns, which produces higher backpressures. On the  other  hand,  even  higher  flow  rates  can  be  used  since  the  tighter  packing decreases  the  interparticle  (outside,  between  particles)  diffusion  as  well  as  the diffusion of analytes between stationary and mobile phase (mass transfer).  Higher flow rates enable the gradients and compounds to be pushed through more efficiently,  and  result  in  narrower  and  higher  peaks.  Another  parameter  that  is beneficial in reducing mass transfer is elevated temperature in the analysis [6] due to  reduction  in  mobile  phase  viscosity.  Nowadays  temperatures  up  to  90°C  are used,  whereas  earlier  the  highest  recommended  temperature  for  silica  based column  particles  was  40°C.  Conventional  silica‐based  particles  may  in  high temperatures undergo hydrolysis of the Si‐O‐Si bond that binds the bonded phase on the silica support [1]. Furthermore, the column material is made more tolerant against phase collapse towards high percentage of aqueous solvent by for example endcapping  chemistries.  Endcapping  also  reduces  unwanted  analyte  interactions 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with  the  silica  support.  In  small  particle  size  columns  the  interaction  surface  is increased  since particle packing  is more efficient. This way  the  chromatographic performance  is  better,  the  efficiency  higher,  the  peaks  sharper  and  higher,  even with short, steep gradients and short run times.  Already  there  is  a  number  of  reports  on  utilising  UPLC  in  multiple  types  of separation analysis [7].   1.1.2. Chromatographic performance  The  chromatographic  performance  of  a  column  can  be  assessed  with  several different  parameters,  including  chromatographic  peak  width  and  height, resolution, selectivity and signal to noise ratios.    Peak width is a parameter describing the peak width in time it takes for the peak to  elute.  It  is  often  described  as  peak width  at  half maximum  (full width  at  half maximum, FWHM). The peak height  is described as signal abundance (counts on detector, i.e. absorbance abundance or abundance of ions hitting the detector plate in MS). Peak symmetry is important in the aspect of column performance, and for example  for  integration.  Most  common  problems  in  peak  symmetry  are  peak tailing or fronting, which makes it more difficult to determine the end or the start of the signal peak. Asymmetry is indicative of poor analyte elution from the column and of inhomogeneous interaction with the stationary phase. It may also be caused by  too  high  sample  volume  or  mass  that  exceeds  the  loading  capacity  of  the column.  Resolution  (Rs)  is  a measure  of  how well  two  analytes  are  separated  from  each other.  Resolution is calculated with the equation   Rs = [1.18(t2 −t1)]/[W0.5,1 +W0.5,2]   where t1 and t2 correspond to compounds’ retention times and the W0.5,1 and W0.5,2 correspond  to  the  peak  widths  at  half  maximum  for  the  respective  peaks. Resolution  value  1  corresponds  to  2%  overlap  of  the  analyte  peaks  (in  case  of Gaussian shaped peaks)[8], baseline resolution is achieved at resolution values of 1.5 or higher.   Selectivity (a) describes the spread of the analytes across the chromatogram. The value is calculated with the help of retention factors (k´), measure of retention of analytes in relation to unretained (tR = t0) peak. Selectivity is the ratio between the retention factor of a later eluting analyte of interest (k´B) and the retention factor of an earlier eluting analyte of interest (k´A).  Retention factor: k´A= (tR, A – t0 )/ t0  Selectivity: a= k´B / k´A  A suitable retention factor for an analyte is commonly considered to be between 2 to 10, to be certain that the analyte does not elute too early and that column and 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the gradient  in use are not  retaining  the analyte  for an unnecessary  long  time.  If the retention factor is too low, the analyte may elute too close to t0, which means that  the  peak  has  not  been  retained  in  the  column.  This  indicates  that  no separation from eventual disturbing sample components occurs.  Selectivity values can be compared for the assessment of gradient functionality, i.e. how  the  selectivity  values  change when  changing  the  gradient  steepness, mobile phase or column.   Signal to noise assessment in chromatography gives the ratio of the signal intensity of a peak divided by the signal intensity of the same signal outside the peak area, the background  (at  a  random range of  time). With  signal  to noise one correlates the peak height into the background noise level, and in this way is able to evaluate limit of detection (S/N 3) and limit of quantitation (S/N 10). This measure is often used for overall measure of the peak detection sensitivity and reliability. The  above  mentioned  parameters  are  used  for  method  developed  for  better separation and detection limits [1].    1.1.3.  Separation of peptides by HPLC  The  principles  of  peptide  separation  have  been  extensively  studied  by  many groups throughout the years (e.g. [9]). The retention of peptides is dependent on the properties of the analytes, the peptides, such as hydrophobities, charge states and sterical effects of the constituting amino acids [9].  Peptide separation has been given a lot attention during the years, [10], especially since  the  emerge  of  proteomics  applications with MS  detection,  and  therein  the shotgun method, where proteins are enzymatically (e.g. with trypsin) digested into peptides  and  the  peptides  detected  and  related  to  the  parent  proteins  [11].  The expected  retention  times  are  considered  important  as  the  identification  of  the detected tryptic peptides can be strengthened by the theoretical estimation of the peptide’s retention time. The comparison of the retention times can be used to add certainty in the analysis.  The  most  common  separation  mode  for  peptides  is  the  reversed‐phase  (RP) chromatography  on  hydrophobic  C‐18  material.  Due  to  the  charged  and hydrophilic  residues  and  the  N‐  and  C‐terminus,  the  peptides  elute  with  low concentrations  of  organic  modifier.  For  the  mobile  phase,  acetonitrile  has  been found to be superior over other organic solvents such as methanol [9] due to lower viscosity, and therefore more effective mass transfer. Trifluoroacetic acid as a pH modifier has benefits in separation and detection due to effective ion pairing and low light absorbance [12]. However, trifluoroacetic acid is not the best option for MS detection due to impaired ionisation caused by ion pairing. 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 1.2. Mass Spectrometry  In mass  spectrometry  (MS)  a  compound  is detected based on  its mass  to  charge ratio (m/z). Mass for a given compound is specific – it is the sum of the masses of the atoms that constitute the molecule, or in the case of MS, the ion. MS can be used for  both  qualitative  and  quantitative  work.  Qualitative,  identification  and structural  elucidation  of  a  compound,  can  be  achieved  by  looking  at  the  analyte mass, preferentially accurate mass,  and  fragmentation patterns. Quantitation  can be achieved by relating the obtained signal abundance with an abundance created by known concentration of the analyte.  The major obstacle  in mass spectrometry was for  long the  ionisation process. An MS  instrument  cannot  process  or  detect  nonionised molecules.  The MS  detector needs  to  receive  ions  in  gas  phase,  that  is,  not  in  physical  contact  with  solvent molecules. Previously only small organic compounds that easily evaporated could be  separated  with  gas  chromatography  and  analysed  by  mass  spectrometer. Especially  biological  macromolecules  are  not  easy  to  get  into  gas  phase.  The developments  in  the  ionisation  have  brought  mass  spectrometry  into  field  of biochemistry and biology.   In  MS  there  are  parameters  that  assess  the  analytical  quality,  such  as  mass resolution,  mass  accuracy,  signal  to  noise  ratio,  linearity  on  a  dynamic  range, quantitational  accuracy  and  precision,  sensitivity  and  selectivity  (assessing probability for false positives or negatives).   All of the above mentioned parameters are more or less dependent on the sample matrix, which  is all  the other compounds  than  the analyte  itself  in a sample. The matrix  may  interfere  with  analyte  detection  (be  isobaric,  i.e.  compounds  with identical  m/z  –ratios),  by  affecting  analyte  ionisation  (ion  suppression  or enhancement) or by simply giving  too strong of a  signal  that masks  the detector from  the  lower  abundance  analyte  responses  (mainly  a  concern  in  the  ion  trap instruments).   LC‐MS  in  general  is  a  selective  detection  method,  where  levels  of  certainty,  or, selectivity,  can  be  added  by  defining  specific  fragments  of  a  precursor  ion  to  be monitored, by looking at a specific collisionally induced fragment of the analyte of interest  (tandem mass  spectrometry). The other way  is  to  look  at  a narrow m/z range  (10‐20  mDa)  for  the  analyte.  Both  of  these  means  greatly  improve  the selectivity  of  the  method  by  reducing  the  probability  of  false  positives  and therefore giving further benefits in quantitative studies.  In low‐resolution instruments, in quadrupoles and triple quadrupoles, as well as in spherical and linear ion traps, the resolution is often defined as Δm, FWHM or as the m2‐m1, where m2 and m1 are separated by 50% valley of the peak height. The resolution  therefore  refers  to  a  small  number,  1  or  less.  The  resolution  in  these above‐mentioned  instruments  is often 1 m/z unit across  the detected m/z  range. Therefore these instruments are often referred to as unit resolution instruments. Mass resolving power is often defined by m/Δm, where Δm is defined as the peak width at half height (Full width at half maximum, FWHM), or where Δm is defined 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as  the m2‐m1, where m2 and m1 are  separated by 50% valley of  the peak height. Therefore the value for resolving power is always a large number. Good mass resolution is required for the elucidation and verification of molecular formula of an ion. It  is also used for determining the ion’s charge state. Detecting the  exact  masses  of  ions  significantly  reduces  the  false  possibilities  in  the calculation of atomic compositions for the ions.  Instrument’s  mass  accuracy  defines  how  correctly  the  m/z  value  can  be determined. MS instruments need to be calibrated with a known set of compounds (e.g. sodium formate clusters)  in order to achieve mass accuracy. One can have a very high mass resolution but still lack mass accuracy if the calibration is off.  The  accuracy  is  often  given  as  error  in  parts  per million,  ppm:  [(mexp  – mexact)/ mexact]*106,  where  mexp  is  the  experimentally  obtained  m/z  for  the  ion  and  mexact  is  the theoretically  calculated  exact m/z  of  the  ion.  The  exact m/z  is  calculated  by  the summation of the constituent atoms’ exact masses divided by the charge. The exact mass is not the same as the usually given molecular weight of a molecule, which in turn corresponds to the average mass of the compounds’ different isotopic forms and their masses.   Signal to noise ratio in mass spectrometry is defined from the mass spectra, where the  signal  for  analyte m/z  peak  is  compared  to  the  background,  i.e.  unspecific signals.  The  unspecific  background may  arise  from  chemical  noise  from  sample components, which is sample specific noise, or electrical, instrumental background noise. With the help of signal to noise –values the limit of detection (LOD; S/N 3; signal  detectable  from  the  background)  and  quantitation  (LOQ;  S/N  10)  can  be determined.   Sensitivity in MS is commonly described by the values of limit of detection or limit of  quantitation  for  a  given  compound  in  a matrix,  the  term  relating  to  signal  to noise values. This definition, however, is stated to be incorrect by Price et al. [13]. According to their definition, sensitivity is the lowest detectable signal in a system where all the parameters are strictly determined. Sensitivity parameter therefore should be reported with units coulombs (C) per microgram of the injected analyte, or as pressure [13] of the analyte in gas form. Therefore in general description of instrument performance one should use the definition of “S/N –values” instead of “sensitivity”.  Quantitative accuracy in MS is generally considered to be acceptable in the range of ±20% [14]. The precisions between MS measurements done on separate days, and between MS measurements between different sample lots (of the same type of tissue) are often described to vary [15]. However, the accuracy, obtained with the help  of  internal  or  external  standards,  is  often  good  [16].  The  lack  of  inter‐day precision in MS is due to inter‐day signal response fluctuations, which is caused for example by the differences in ion source cleanliness (affecting ionisation) etc.  Linearity  on  a  dynamic  range  is  important  in  quantitation.  The  dynamic  range corresponds to the signal responses in a given range of concentrations of analytes, 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and in mass spectrometry this range between LOQ to signal saturation is expected to be 3 to 4 orders of magnitude depending on the instrumentation.    In  mass  spectrometry  all  of  the  isotopic  forms  of  the  compound  are  recorded according  to  their  abundance,  and  the  isotopic  pattern  produced  is  additional information. The  isotopes differ by  the number of neutrons  in  the atoms, e.g.  the presence of  13C  is statistically 1%. Therefore,  in a molecule containing 50 carbon atoms,  the  probability  of  at  least  one  of  them  being  13C  is  0.01*50=  0.5,  and therefore  the  isotopic  pattern  has  as  a  second  m/z  peak  (in  addition  to  the monoisotopic  ion species)  in the abundance of ½ of the first  isotope m/z peak in the  mass  spectra.  As  the  number  of  carbon  atoms  increases,  the  probability  of having  at  least  one  (or  further  on,  two,  three,  or  four  etc.)  13C  increases,  and therefore  the  relation  between  the  two  m/z  peaks’  abundance  is  changed accordingly. Parts of the elementary composition can sometimes be deduced from a characteristic  isotopic pattern. As an example,  in  the presence of  chlorine  (35Cl 76%  37Cl  24%) or  bromine  (79Br 50.5%,  81Br 49.5%)  give  characteristic  isotopic patterns. The isotopic patterns are especially useful in high‐resolution instruments where experimentally obtained spectra can be matched to theoretically calculated spectra for compound identification [17]. Most importantly, the isotopic pattern can be used to reveal the charge state of the ion. With organic compounds, singly charged ions have the one mass unit isotopic peaks separated by 1 m/z (Δm =1 from 1 neutron difference, z= 1), doubly charged ions by 0.5 m/z (Δm =1, z= 2), and triply charged ions by 0.333 m/z (Δm =1, z= 3) etc.   1.2.1. Ionisation  techniques  that  enable  the  use  of  MS  with  biological macromolecules  The  discoveries  in  the  1990’s,  electrospray  ionisation  (ESI)  [18]  and  matrix‐assisted lased desorption/ionisation (MALDI) [19], enabled the mass spectrometry instrumentation  to  be  utilised  for  biological  samples  for  analysis  of macromolecules.  Biological  macromolecules,  such  as  proteins,  peptides, carbohydrates and nucleic acids, are water soluble, and neither evaporates easily, nor  are  thermally  stable  and  therefore  not  suitable  for  the  traditional  ionisation methods.  For  quantitative  purposes  one  often  uses  the  ESI  source.  Before  these ionisation  sources,  sources  such  as  chemical  ionisation  (CI),  electron  ionisation (EI)  and  fast  atom  bombardment  (FAB)  and  secondary  ion  mass  spectrometry (SIMS)  were  used  for  the  ionisation  of  smaller,  and  usually  thermally  stable compounds. Nowadays there are even further possibilities  for  ionisation sources, one  can choose atmospheric pressure  chemical  ionisation  (APCI) or atmospheric pressure photoionisation  (APPI) or any of  the  traditional methods. However,  the main ionisation source nowadays for the biological analytes is the ESI. See table 1.1 for  the  summary  of  different  ionisation  sources  currently  used  in  LC‐MS  and  in analysis of spotted biological materials or tissue sections in mass spectrometry.  Electrospray ionisation coupled to liquid chromatography In ESI the mobile phase from LC is directed through a metal capillary that carries high  voltage.  The  solvent  is  pushed  through  the  needle,  and  the  voltage  induces charges,  i.e.  ionises molecules within  the  solvent  passing  through.  pH modifiers, 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such as acids  in  the mobile phase, are used  to  fortify  the  ionisation. The charged solvent then forms a fine mist of droplets, repelling each other because of the same polarity  of  charge.  The  solvent  is  further  vaporised with  the  help  of  heated  gas flow, and therefore the droplets become even smaller. The charge remains on the surface  of  the  droplet  and  at  a  certain  point,  when  the  droplet  is  highly concentrated with  charged  ions,  the  repulsion  breaks  the  droplet  and  gas  phase ions  are  released  into  the  source  by  coulombic  explosion.  The  formed  ions  are thereafter  pulled  into  the  mass  spectrometer  by  another  voltage,  and  further inside in the instrument by increasing vacuum and with the help of voltages of the ion optics.  The ESI process  ionises most analytes, especially  in  the positive  ion mode. When the solution is acidified, many different types of compounds in the sample matrix will easily obtain positive charge in the ESI source. This creates high background noise from the sample and also increases the possibility for matrix effects.  ESI  is  a  flow  dependent  ionisation  process,  where  the  ionisation  efficiency  is dependent  on  the  flow‐rate,  the  liquid  composition  (solvent  properties  such  as surface  tension  and  boiling  point),  pH,  and  the  salt  concentration  of  the  solvent introduced [20]. In general one uses acidic volatile pH modifiers with the positive mode  detection  (ions  are  created  by  protonisation)  and  pH  close  to  neutral  or basic in the negative mode detection (deprotonated ion species). However, for the LC  separation  acidic  pH  is  preferred  and  Schiesel  [21]  noticed  higher  signal intensities in negative mode with mobile phase pH 5 than with pH 9.  The APCI source  in connection  to LC  is often  less sensitive  to matrix effects  than ESI source [22]. Furthermore, the negative mode in both ESI and APCI sources give lower  ionisation  efficiency  (less  compounds  are  ionised  into  the  [M‐H]‐  species than  to  the  [M+H]+  species.  This means  that  if  a  compound of  interest  is  readily ionised into the negative species it might be useful to analyse the compound in that mode in order to have reduced background noise and thereafter higher S/N values and better sensitivity [22].   Characteristic  to  ESI  are  the multiply  charged  species,  and  a  series  of  different charge  states  of  the  same  molecule.  One  compound  may  be  seen  in  several different  charge‐states  depending  on  the  number  of  ionisable  groups.  Multiple charged ions that have more than one ionisable group within the structure, create richer  fragmentation  patterns  in  tandem MS,  and  therefore  give more  structural information of the ion. The ESI ionises molecules also with ions other than protons, and therefore creates further ion species, e.g. with Na+, K+, NH4+ adducts in positive mode or Cl‐ adducts in negative mode. In ESI the detection and quantification of a given compound can be  determined  on  multiple  spectral  components,  with  singly/multiply  ionised protonated  or  adducted molecules,  and/or with  fragment  ions  from  the  original molecule.  Nonvolatile solutes may induce ion suppression matrix effect by competing of the ionisation with the analyte [23] in the solvent droplets in the ESI source [20]. High concentrations of analytes, matrix compounds or too high of a water content in the spray solution may produce disturbances in the conductivity of the ESI spray [24]. 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 1.2.2. Different types of mass analysers  Mass analysers can be divided into four different subgroups: 1) magnetic sector 2) time‐of‐flight (TOF), 3) quadrupole (Q) and 4) Fourier transform (FT) analysers. Of these  four  groups  mainly  the  three  last  mentioned  are  used  for  biological molecules.  The  magnetic  sector  instruments  are  mainly  used  in  the  study  of smaller  molecules  with  a  flexible,  but  narrow  mass  range.  The  TOF  and  the quadrupole type instruments can be used for quantitative analysis, the TOF having a far wider mass range and higher resolution than the Qs, whereas the QQQs have the  shortest  duty  cycles,  and  are most  sensitive  and  reliable  for  the quantitative purposes.  FT  instruments  are  mainly  used  for  high  accuracy  mass  studies  for especially structural determination.    1.2.2.1. Time‐of‐flight (TOF) instruments  TOF has the easiest mass analysis principle to understand: the ions are separated by  their  flight  time.  Ions are given a certain kinetic energy by an accelerator,  the amount of energy depending on the charge of the  ions, but not depending on the mass of the ions. Therefore the lower mass to charge ratio ions gain higher speed. The flight time is dependent on speed and therefore the smaller m/z ions arrive to the detector plate  first.  To have  even higher  resolution  in  the detection  the  ions can be reflected back to the field free flight tube in order to double the flight path and therefore double  the difference created by  the different m/z  in  the  ions. The TOF instrumentation has gained its current usability due to the inventions made in the  1980s,  such  as  the  use  of  reflectrons  for  longer  flight  path  [28]  and delayed extraction,  or  time‐lag  focusing,  for  sharper  mass  peaks.  Other  important developments have been the orthogonal accelerator and the speed of  the analog‐ to  digital  converters  for  the  data  acquisition.  Before  these  developments  the instrumentation  was  lacking  the  current  main  advantage  of  having  high  mass resolving power with fast scan rates.    1.2.2.2. Quadrupole (Q) instruments   Transmission quadrupole mass spectrometers, or, quadrupoles (Q) are mass filters that  only  let  through  a  specified mass  range  (i.e.  one mass  unit)  at  a  time.  The electric  field  created  by  the  radio  frequency  (RF)  amplitude  and  constant  direct current (DC) potential stabilises only one mass range at a  time, and all  the other ions  are  discarded.  Although  capable  of  only  unit  resolution,  for  a  quantitative study  the most popular  instrument  still  is  a  triple quadrupole  (QQQ). Usually,  in the first quadrupole the ion of interest is selected, in the second fragmented and in the third scanned, or a  fragment of  interest selected (see figure 1.2). With a QQQ instrument  there  are many  scanning modes  available  (see  figure  1.2),  and  some useful options for function that are not possible in other types of instruments. 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The  characteristic  functions  include neutral  loss  scan  and precursor  ion  scan.  In neutral loss scan the loss of certain mass, [X] (functional group, e.g. phosphate, or water  molecule),  gives  rise  to  a  fragment  that  has  a  mass  of  M‐X  which  is  the filtering  mass  to  charge  ratio  for  the  third  quadrupole  before  the  ions  hit  the detector. In precursor ion scan, the first quadrupole is scanning, whereas the third quadrupole  sits  on  one  specific mass  to  charge  ratio.  The  second  quadrupole  is fragmenting the ions from the first quadrupole. The precursor ion scan function is good  for  scanning  for  compounds  with  a  similar  functional  group  such  as metabolites of a common drug / other compound, or other similar fragmentation product (see figure 1.2).   1.2.2.3. Spherical and linear ion trap instruments  Quadrupole  type  ion  trap  mass  spectrometers,  linear  or  spherical,  three‐dimensional  (a  Paul  trap)  ion  traps  have  the  same  physical  principals  for  ion detection and selection as quadrupoles, but the functions are rather different. The ion traps can be used  for sequential stabilisation‐  fragmentation and  ion ejection events  and  in  this  way  further  structural  information,  specific  fragments,  are obtained from molecular species.  In other words, whereas the different functions for  ion selection and  fragmentation  in QQQs are separated by space,  in  ion  traps those  functions  occur  in  one  place,  the  ion  trap,  but  the  different  functions  are separated by time. Whereas in a QQQ an ion can only be fragmented in the second quadrupole  (plus,  less  specifically,  in  the  ion  source  by  applying  higher  voltage) the fragmentation may in a quadrupole ion trap be repeated over and over again, to  create  MSn  fragmentation.  Furthermore  the  quick  scanning,  trapping  and sequential ejection of ions of a wide range of m/z gives advantage in the detection of previously unknown, or unexpected analytes in a sample.   Some of the same type of functions as for the triple quadrupole can, in principle, be performed in a spherical  ion trap, however with a major difference: whereas in a true QQQ MRM ‐experiment only one fragment ion species at a time is let through, in  an  ion  trap  the  whole  fragmentation  pattern  is  scanned,  and  then  a  specific fragment  is  afterwards,  during  data‐analysis  chosen  for  analysis.  The  main drawback in using the ion trap for MRM is the time cycle: The trap needs to take in, stabilise in the trap, and successively eject all of the trapped ions to the detector. This creates a far longer duty cycle time than just swiftly changing the DC current for ion filtering in a QQQ instrument.   1.2.2.4. Fourier transform (FT) instruments  FT  (Fourier  transform)  instruments  nowadays  include  two  types  of  mass analysers,  the  ion  cyclotron  resonance  (ICR)  [29]  and  Orbitrap  [30]  type instruments.  The  ICR  instruments  require  a  high magnetic  field,  and  therefore  a large magnet  for  the  ion stabilisation  into a circular  ion path, orbital, whereas  in the Orbitraps  the  ions  are  stabilised  into  an  axial  oscillation  ion path  around  an electrode, or orbital. The fact that the great magnet is not needed in the Orbitrap offers  great  benefits  in  instrument  maintenance  and  operating  costs.  The  FT instruments  utilise  the mathematical  equation  Fourier  transform  to  convert  the 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 1.2.3. Quantitative mass spectrometry analysis  LC‐MS  detection  is  well  suited  for  quantitative  analysis,  provided  that  suitable standards  are  available.  However,  the  sample  needs  to  be  prepared  for  the analysis. The  importance of  sample preparation was recognised by van Leeuwen [32], where differences in results were noticed in the same way treated samples in different  laboratories.  Hyötyläinen  mentioned  sample  preparation  as  the  main source of error in the analytical work‐flow [33].  The purpose of sample preparation is to selectively extract, to recover, the analytes of  interest  from  the  matrix  and  leave  the  interfering  compounds  out  of  the processed  sample.  The  purpose  is  also  to  concentrate  the  sample  so  that instrument  sensitivity  is  enough  for  detection. As  a  general  rule,  all  the  samples need  to  be  processed  in  some  way  prior  to  mass  spectrometric  analysis.  The sample  preparation,  sometimes  laborious,  often  is  the  bottleneck  for  sample throughput.  In quantitative analysis precision  in  sample preparation  is  crucial  in maintaining  the  samples  as  comparative.  Sample  preparation  should  consider aspects  like  analysis  goal  (multiple  or  one  target),  sample  stability,  available standards, and assessment of signal responses (spiking studies).    1.2.3.1. Analysis goal  In mass spectrometry many different analytes can be looked at simultaneously, but on the other hand, for quantitative purposes, all of the analytes of interest need a standard  to  relate  the  signal  response  to  the  concentration of  the analyte. Multi‐compound  analysis  also  changes  the  sample  preparation  goal  in  the  sense  that highest  selectivity  cannot  be maintained,  but  the purpose  is  to  include  all  of  the different analytes of interest in the processed sample [34].    1.2.3.2. The  use  of  standards  –  internal  standards  vs.  external standards  In quantitative analysis two types of standards can be used: internal standards (for example isotopically labelled analytes) or external standard. The internal standard is spiked into all samples in an equal amounts, whereas the eternal standard signal response will be related  to  the sample signal response  from a separate (adjunct) run.  In  the  case  of  an  external  standard,  the  standard  can,  and  should  be,  the analyte itself.  The use of  internal  standards  is not only  recommended  for  the determination of sample  preparation  efficiency,  but  also  required  for  the  estimation  of  the instrument  behaviour  and  signal  responses.  Internal  standards  were  found beneficial in a systematic study of different types of biomolecules by Schiesel et al. [21,  35].  The  usefulness  was  proven  in  both  in  analysis  accuracy  and  interday precision. 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 1.2.3.3. Assessment of signal responses – spiking studies  Spiking studies are crucial in order to define the effect of the matrix to the analyte ionisation. Matrix effects are sometimes difficult  to understand, especially matrix enhancement. Great matrix enhancement effects have been reported eg. in [36‐37].  Schiesel et al [21, 35] found variable matrix effects for different compounds in the same matrix, and found matrix effects to be a major source of inaccuracies in case not  corrected  for  by  spiking  studies  [35].  Furthermore  the  instrument  response fluctuation (ion source contamination due to extensive sample series with complex sample  matrix)  was  found  to  decrease  accuracy.  These  inaccuracies  can  be corrected by the utilisation of internal standards or by external standards [35].   1.2.4. Current trends in mass spectrometry  Mass spectrometry instrumentation can be used multiple ways. Nowadays the fast duty  cycles  and  software  development  enable  functions  previously  unavailable. Modes  that  enable  the  acquirement  of  different  types  of  data  in  one  run  may include  ‐ isotopic pattern triggered product ion scan initiates  fragmentation  and  scanning  of  a  compound  consisting  of  characteristic isotopic pattern (e.g. containing Cl or Br) ‐ enhanced product ion scan, for the use of an linear ion trap for a high quality MS spectra, ‐  polarity  switching  in  single  runs, where  compounds  can  be  screened with  two different modes in a single run ‐ polarity switching used in negative precursor ion triggered positive product ion scan,  can  be  used when  the  analyte  shows well  and with  less  noise  on  negative mode, but  fragments poorly,  for example gives only a water  loss, on the negative mode. ‐ constant neutral loss scan for certain functional group or biological modification (e.g. glutathione adduct),  ‐ MRM (of 100 transitions) triggered product ion scan, where multiple spectra can be obtained during one run,  ‐ mass defect  triggered MS‐MS, where  for example exogenous compounds rich  in double  bonds  or  sulphur,  chlorine  or  phosphor  can  be  surveyed  by  initiating fragmentation when negative mass defect is detected.  All  of  these modes  have  been  utilised  in  drug metabolite  research  (reviewed  in [38]).  The  usual  product  ion  scan  function  benefits  in  selectivity  from  the utilisation  of  accurate mass  (TOF  or  FT  instrument)  detection  for  the  triggering precursor  ion.  The  combination  of  a  quadrupole  to  linear  ion  trap  has  brought benefits in MS‐MS scans and MSn measurements. Data mining and data processing after LC‐MS runs are essential in pointing out the relevant observations.   The  Orbitrap,  released  in  2005,  has  revolutionised  the  accurate  mass  field  by providing FT‐ICR comparable resolution without the large magnets and therefore space and electricity requirements. Whereas  the FT‐ICR utilises  the circular path 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oscillation  frequency  in  the  cell  for  the determination of  spectra,  in Orbitrap  the recorded  oscillation  is  in  the  axial movement  around  the  spindle‐shaped  central electrode. The addition of double stage linear ion trap in the front gives benefits in speed in the first stage analysis, while only selected ions are selected for accurate mass measurement in the Orbitrap [30]. Another interesting instrument development is the coupling of ion mobility flight tube in front of a time‐of‐flight instrument [39]. This set‐up has been shown to give benefits  in  the  detection  and  identification  of  (highly)  branched  carbohydrates where the analysis might be very demanding due to many structural isomers [40] and in the detection of peptides and proteins [41]. 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 1.3. Cyanobacteria and their toxic metabolites  Cyanobacteria are among the oldest organisms in the world: they were responsible for  creating  the  oxygen  atmosphere  on  earth  (reviewed  in  [42])  and  there  is evidence of cyanobacteria already from about 3.5 billion years ago [43]. There are about  150  genera  and  2000  species  of  cyanobacteria,  they  belong  to  the  gram‐negative  bacteria  ([44]).  Cyanobacteria  have  vital  roles  in  cycling  biochemical nutrients,  they  function  as  nitrogen  fixers,  and  therefore  in  the  maintenance  of biodiversity  of  microbial  and  higher  organisms  [45].  Most  commonly cyanobacteria  inhabit water  bodies,  lakes  and  seas,  but  they  are  encountered  in most  variable  environments,  desert  sand  and  volcanic  ash,  in  temperatures ranging from those of hot springs to the Arctic and Antarctica (reviewed in [42]). Also,  cyanobacteria  have  roles  as  symbiots  in  different  types  of  plants.  The problems  with  cyanobacteria  occur  mostly  in  regions  where  water  bodies  are warm throughout the year and contain nutrients in excess.   Cyanobacterial blooms occur frequently all over the world. They cause hypoxia in the water bodies during bloom disintegration,  leading  into problems  for  fish and other organisms in the water bodies.  Besides the blooms themselves, the toxic genera of cyanobacteria (about 40 out of the  150  genera  of  cyanobacteria  (reviewed  in  [46])  cause  problems  to  the organisms  depending  on water  resources.  The  oldest  scientific  report  on  animal toxicosis was written by Francis in 1878 [47]. Reported human exposure cases are from both short‐term exposure incidents as well from long‐term exposure. Short‐term exposure cases in Brazil have been reported by Teixeira and co‐workers from Paulo Afonso [48], and e.g. by Jochimsen and co‐workers [49] from Caruaru. Short‐term exposure cases from Australia have been reported by Byth [50] and Bourke and co‐workers [51]. Long‐term exposure has occurred  in China, as described by Ueno  and  co‐workers  [52].  Less  severe  incidents  have  occurred  for  example  in Sweden,  reported  by  Annadotter  [53]  and  in  the  UK  by  Turner  and  co‐workers [54].   There are many different classes of biologically active compounds produced by the different  species  of  cyanobacteria.  The  classes  comprise  of  hepatotoxic  cyclic peptides microcystins (MCs) and nodularins (Nod), cytotoxic cylindrospermopsin, neurotoxic  anatoxin‐a  and  –a(S),  saxitoxin  and  saxitoxin  analogues,  neurotoxic amino  acid β‐N‐methylamino‐L‐alanine  (BMAA)  and  irritating  agents  (non‐toxic) lipopolysaccharides. See table 1.3 for an overview of the produced toxins and their toxicities. The information in this table is mainly based on [55‐57] and completed with information from [58‐62]. 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 1.3.1. Cyanobacterial peptide hepatotoxins  The  structure  of  the  cyanobacterial  peptide  hepatotoxins  is  unordinary  to biological peptides, they comprise seven (MC) or five (Nods) amino acid residues in a cyclic structure, the amino acid residues being both common or uncommon (D‐amino acids as well as other characteristics in the sidechains) amino acids (Figure 1.3).  Characteristic  Adda  (2S,3S,8S,9S)‐3‐amino‐9‐methoxy‐2,6,8‐trimethyl‐10‐phenyldeca‐4(E),6(E)‐dienoic  acid  is  by  definition  found  in  all  MC‐  and  Nod  ‐structures.  There  are  over  100  variants  of  MCs  described  in  the  literature,  the structure  in  general  being  cyclo(‐D‐Ala(1)–X(2)–D‐MeAsp(3)–Z(4)–Adda(5)–D‐Glu(6)–Mdha(7)). Mdha stands  for N‐methyldehydroalanine. Table 1.4 presents  the  latest MC variants to have been published, and completes the lists compiled by Sivonen and  Jones  [55]  and  presented  in  Dr.  Lisa  Spoof’s  doctoral  thesis  [63].  There  are about 10 variants of Nods.  Table 1.4. Recently reported novel MCs. Table compiled by Dr. Lisa Spoof, manuscript under preparation.   Microcystin  MW  Organism  Reference [D‐Asp(3),dmAdda(5)]MC‐LA   881  Hapalosiphon hibernicus BZ‐3‐1  [64] [D‐Asp(3)]MC‐VA  881  Hapalosiphon hibernicus BZ‐3‐1  [64] [Asp(3)]MC‐LA  895  M. aeruginosa B2666  [65] [D‐Asp(3)]MC‐LA  895  Hapalosiphon hibernicus BZ‐3‐1  [64] [D‐Asp(7)]MC‐LA  895  Hapalosiphon hibernicus BZ‐3‐1  [64] MC‐VA  895  Hapalosiphon hibernicus BZ‐3‐1  [64] [D‐Asp(3)]MC‐LV  923  Hapalosiphon hibernicus BZ‐3‐1  [64]  [Asp(3),Dha(7)]MC‐YA  931  M. aeruginosa  [66] [Asp(3)]MC‐LL  937  M. aeruginosa B2666  [65] MC‐LV  937  Hapalosiphon hibernicus BZ‐3‐1  [64]  [D‐Asp(3)]MC‐RA  938  Hapalosiphon hibernicus BZ‐3‐1  [64] [Gly(1), Asp(3)]MC‐LR  966  Nostoc, Miers valley, Antarctica  [67] MC‐AhR  967  Microcystis sp. Adityanagar pond, India  [68] [Gly(1), Asp(3)]MC‐LhR  980  Nostoc Miers valley, Antarctica  [67] MC‐VR  980  Microcystis MK10.10, Vistula Lagoon, southern Baltic  [69] [D‐Asp(3), (E)‐Dhb(7)]MC‐hIR  994  P. rubescens  [70] [Gly(1), Asp(3), AdmAdda(5)]MC‐LR  994  Nostoc, Miers valley, Antarctica  [67], [Gly(1), Asp(3), AdmAdda(5)]MC‐LhR  1008  Nostoc, Miers valley, Antarctica  [67] [methylated Ala(1)]MC‐LR or [methylated Leu(2)]MC‐LR  1008  * Lake Suwa bloom  [71] [Gly(1), Asp(3)]MC‐RR  1009  Nostoc, Miers valley, Antarctica  [67] MC‐ER  1010  *  [65] MC‐MR  1012  *  [72] [Gly(1), Asp(3)]MC‐RhR  1023  Nostoc, Miers valley, Antarctica  [67] [Asp(3)]MC‐RY  1031  * Uganda  [73] [Gly(1), Asp(3), AdmAdda(5)]MC‐RR  1037  Nostoc, Miers valley, Antarctica  [67] [MeAsp(3)]MC‐RY  1045  * Uganda  [73] 
  37 
[Ser(7)]MC‐YR  1048  * Lake Suwa bloom  [71] [Gly(1), Asp(3), AdmAdda(5)]MC‐RhR  1051  Nostoc, Miers valley, Antarctica  [67] [NmeSer(7)]MC‐YR  1063  * Uganda  [74] MC‐hRhR  1065  *  [75] [9‐AcO‐Adda(5)]MC‐RR  1066  Planktothrix rubescens, 
 Lake Averno, Italy  [76] * Producer not determined Some abbreviations: hR homoarginine, AcO acetyl, AdmADDA acetyldemethylADDA, dhb dehydrobutyrine, hI homoisoleucine, NMeSer methylserine, Dha dehydroalanine  The  characteristic  amino  acid  Adda  and  the  acidic  group  in  the  Glu  residue  are required  for  the MC and Nod  toxicity, as well as  the cyclic structure of  the  toxin. The MC variants differ in toxicity: in the literature reported values range from the very potent toxin MC‐LR, LD50 (mouse i.p.) of 50 µg/kg, to MC‐RR, LD50 (i.p.) of 600 
µg/kg, and to the Adda ‐modified MC:s LD50 (i.p.) of over 1000 µg/kg (reviewed in [55]). Modification in the Adda structure or opening of the ring structure renders the molecule  to a  less  toxic  form (reviewed  in  [42]). The Adda amino acid on  its own is not toxic [77].  
   Figure 1.3. The structure of  cyanobacterial hepatotoxic cyclic peptides, microcystins and nodularins. The structures have either seven or five amino acids in a cyclic structure, and contain some uncommon amino acids such as the Adda‐amino acid. Adda has a conjugated diene  in  the side chain, which  is a key element  for  the  typical absorption spectra  in UV‐detection.   MCs and Nods are taken up into the cells, in animals mainly hepatocytes, through the organic anion transporting polypeptides (OATP) [78], formerly called bile acid 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transport  system,  as  they  are  unable  to  penetrate  the  cell  membrane  [79].  The more lipophilic congeners such as MC‐LW and MC‐LF were shown to interact more efficiently with a model membrane than MC‐LR, suggesting more interactions with cell membranes [80].   The MCs and Nods are potent and specific inhibitors of protein phosphatases (PPs) 1 and 2A [81‐83]. MCs, but not the related Nod toxins [84], form a covalent bond with  target  proteins,  PPs,  after  hours  of  exposure  [85].  Both  covalent  and noncovalent  interactions with the PPs give rise to effective  inhibition. The IC50 of the most common variant, MC‐LR for the mammalian PP1 has been reported as 1.7 nM  and  for  mammalian  PP2A  0.04  nM  [82].  For  Nod‐R  the  corresponding  IC50 values were 1.8nM and 0.026 nM respectively [86]. The  noncovalent  interaction  is  directed  by  the  Adda  side  chain  burying  into  a hydrophobic pocket in the protein phosphatase [87]. The covalent bond is formed between N‐methyldehydroalanine  (Mdha)  residue  double  bond  and  the  cysteine 273  residue  in  PP1  [87‐88],  or  the  corresponding  residue  cysteine  269  in  PP2A [89] (Figure 1.4).   
  Figure 1.4. Three‐dimensional  structure  of  MC‐LR  covalently  bound  to  the  target  protein,  protein phosphatase  1,  obtained  by  x‐ray  crystallography.  The  MC‐LR,  and  the  covalent  bond counterpart  the  Cys  273  residue  are  in  ball  and  stick  model,  whereas  the  protein secondary structures are shown  in ribbons (alpha helices) and sheets  (beta sheets). The manganese ions required for the activity in the active site are rendered as cyano‐coloured balls. PDB ID 1fjm; Goldberg and co‐workers [87]  In  a  wide  selection  of  eukaryotic  organisms,  including  mammals,  bivalves, zooplankton,  and  plant  species,  the  IC50  for  protein  phosphatase  1  and  2A inhibition by MC‐LR falls into the narrow range of below 0.1‐0.25 nM [83, 90‐91]. The  protein  phosphatase  variant  PP2A  from  maize  (Zea  mays)  has  the  lowest reported  IC50:  0.03  nM  [92].  Since  more  than  97%  of  protein  phosphates specifically  dephosphorylate  the  serine  or  threonine  residue‐linked  phospho‐groups,  the  inhibitory  effect  of  MCs  to  the  Ser/Thr‐phosphatases  is  likely  to 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interfere with many pathways in the cell (see [93]). The result of these toxins is the overall increase in phosphorylation of the regulatory proteins. The main target for the toxins in mammals, fish and birds is the liver.  A  phosphoproteomics  study  by  Tachi  and  co‐workers  [94]  suggests  that  the morphological changes such as swollenness and darker colour of liver tissue, and apoptosis would be a consequence of PP2A  inhibition, which  is a common target for both MCs and okadaic acid [95]. The acute toxicity of MCs (not occurring with OA in liver cells) would then be related to PP1 inhibitory effects [94].  Mikhailow and co‐workers have shown that also ATP synthase  is a  target  for MC inhibition  [96].  This might  explain  the  apoptotic  effect  of  high  concentrations  of MCs in cells [96]. The possible other candidates for MC toxicity in mouse liver were studied  by  Imanishi  and  Harada  [95],  where  they  found  that  in  addition  to  the PPase  family also some calmodulin binding proteins, striatins specifically bind to MC‐LR.    1.3.2.  Bioaccumulation  and  concentrations  of  peptide  hepatotoxins  in animal and plant tissues  The  levels of  cyanobacterial  toxins  in natural waters have been reported  to vary between  0  to  up  to  25000  µg/l  (reviewed  in  [42]).  The  usually  reported extracellular concentrations of MCs (not  including the occasion of a heavy bloom breaking down) are, however, much lower, in the range of 0.1‐10 µg/l (reviewed in [55]).   There  are  extensive  reviews  on  the  subject  of  animal  and  plant  exposure  to cyanobacterial toxins [97‐98]. Accumulation occurs in bivalves, molluscs, fish and aquatic  plants  through  filtering  the  contaminated  water  and  by  consumption  of toxic cyanobacteria. Accumulation has also been shown up  in the trophic  level  in the  food  web  by  animals  feeding  on  contaminated  food,  such  as  mussels  and aquatic snails by predatory fish, birds etc. [99] (see fig. 1.5). Baltic Sea ecosystem has been found to contain Nod on many organism levels (reviewed in [100]): Baltic sea Nodularia spumigena has been reported to produce up to 18100 µg of Nod/g dry weight  (DW)  phytoplankton  [101],  releasing  up  to  18100  µg  of Nod/l  [102] into  the water bodies. Despite  these very high  toxin concentration values of only up to 2 µg of Nod/g DW tissue has been reported from higher organisms (mussels) in  the  Baltic  Sea  [103]  (see  figure  1.5.  for  information  compiled  by  Harri Kankaanpää). The main  accumulation  site  is  the hepatopancreas  in bivalves  and the liver in fish and birds.   MC  ‐accumulation  in  fish,  mussels  and  aquatic  snails  has  been  thoroughly inspected  (see  review  [98]).  Majority  of  the  accumulation  studies  have  been conducted with the ELISA method that is not designed for tissue analysis, but for water  samples  (see section 1.5.2.2). Therefore cross‐reactivity and matrix effects and  extraction  efficiency  may  have  affected  the  accurate  determination  of  the concentrations.  Furthermore,  the  total  amount  of  toxin  (free,  plus  covalently bound  to  the  target  proteins)  remains  a  question when  the  toxins  are  extracted from the tissue. The true values of the total toxin concentrations might have been 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underestimated.  It  is  also unclear  if  the  covalently bound  toxins  are bioavailable for  the  next  trophic  level  [104].  Furthermore,  the  possible  biotransformation products of the toxins might not be detected with ELISA.  There  are  not many  studies  published  of  MC  transfer  from  one  trophic  level  to another  in  the  food  chain.  In  an  extensive  study  of  three  years  lake monitoring, food  chain  starting  from  filter  feeder  zooplankton  (mainly Daphnia galeata) was found  to  be  contaminated  with  MCs,  whereas  food  chain  starting  from  another filter feeder zebra mussel Dreissena polymorpha was found to be rather clean from MCs [105]. The concentrations found in the first consumer organism were for the zooplankton, Daphnia galeata, up to 1000 µg of MC/g DW, on average in the range of 63‐211 µg of MC/g DW, and for the zebra mussel Dreissena polymorpha up to 30 µg of MC/g DW, on average in the range of 2‐12 µg of MC/g DW [105].  
  Figure 1.5. In  the Baltic sea the aquatic organisms such as mussels,  flounders and stickelbacks have been  shown  accumulate  high  amounts  of  Nod‐R  in  their  tissues.  The  eider  ducks  that consume mussels as a part of their diet accumulate the toxin as well. The figure is modified from  Harri  Kankaanpää’s  (Finnish  Environment  Institute,  Marine  Research  Centre) presentation in 2004.   1.3.2.1. Fish, bivalves and aquatic snails  Reported toxin levels in different aquatic organism tissue range between 436 µg/g DW (in freshwater snails exposed in laboratory conditions) [106], and to 420 µg/g DW  (bivalves  in  a  hypereutrophicated  lake  in  Japan)  [107]  to maximum  of  49.7 µg/g  (in  laboratory  experiment  exposed  fish)  and  in  general  in  the  range of  few 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hundred ng of MCs/g DW in crab and  fish  tissue (reviewed  in [98]). As  the main target  organ  in  fish  is  the  liver,  only  minute  amounts  of  the  toxins  have  been detected in the fish muscle tissues [99]. In the case of a heavy blooms in a Japanese lake  the  difference  between  accumulation  into  different  species  of  bivalves  was noticeable, from a max value 12.6 µg of MCs/g for Anodonta woodiana to 297 µg/g in Cristaria plicata and 420 µg/g in Unio douglasiae [107].  Interestingly,  the  bivalves  are  able  to  survive  despite  the  considerable accumulation of MCs in the tissues, although their IC50 protein phosphatase 2A was determined to 0.25 nM [83, 91]. Mussel insensitivity towards okadaic acid and the marine  dinoflagellate  diarrhetic  shellfish  poison  (DSP)  toxin  has  been  reported [108],  but  the mechanism  explaining  insensitivity  towards MC  has  not  yet  been identified [97].   1.3.2.2. Birds  In a study by Chen et al. MCs in the small intestinal and stomach contents as well in the  livers  of  the  ducks  and water  birds were  in  the  range of  12  ‐  42.0  ng/g DW [109].  In  the  same  study  the  egg  yolk  also  showed  some  accumulation  with concentrations in the range of 7 ‐ 15 ng/g DW tissue. Analyses of Baltic Sea eiders by ELISA and LC‐MS showed that eider liver samples contained  3  to  180  ng  of  Nod/g  DW  [110].  In  a  similar  study  conducted  in  a different year eider  liver samples contained Nod up  to 199 ng/g DW and muscle samples up to 21 ng/g DW as measured by LC‐MS [111].  Birds are known to accumulate some toxins into their feathers [112‐113]. The first report of cyanobacterial hepatotoxins, MCs, in bird feathers was done by Metcalf et 
al.  [114].  These  birds,  lesser  flamingos,  had  earlier  been  reported  to  have  been exposed  to  cyanobacterial  toxins.  The  reported  concentrations  from  different tissues were in stomach, intestine and fecal pellets of 196 ng/g fresh weight of MCs and 4.34 µg/g fresh weight of anatoxin‐a [115].    1.3.2.3. Humans  WHO has  provided  a  provisional  guideline  of  1  µg/l  of MC‐LR  in  drinking water [116].  This  guideline  is  based  on  a  44‐day  long  exposure  study  on  pigs  [117]. However,  Ueno  et  al.  [52]  have  criticised  this  value  and  suggested  a  stricter guideline value of 13 ng/l MCs, especially for drinking water consumed in areas of high  occurrence  of  primary  liver  cancer.  Their  study  is  based  on water  samples collected  in  China  to  estimate  the  effects  of  long‐term  exposure  of  humans  to cyanobacterial toxins [52] (see more in human risk assessment, section 1.4.). In a second, more recent study from China Chen and co‐workers have detected MCs on average  0.39  ng/ml  in  human  serum  samples  taken  from people  exposed  to  the MCs below the range of WHO guideline values [118]. The authors had also looked for indicators of MC‐induced liver damage from the blood samples [118] and found positive  correlation  between  MC  concentrations  and  concentrations  of  enzymes alanine‐  and  aspartate  aminotransferase,  alkaline  phosphatase,  and  lactate dehydrogenase. They conclude that either the exposure levels had in reality been higher than what their data shows, or that the WHO guideline values would need to be reassessed since liver damage had already occurred [118]. 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In  the  extensively  studied  Caruaru  dialysis  clinic  case  in  1996  the  human poisonings  could  be  traced  back  to  MCs  and  cylindrospermopsin  with  high confidence. The patients had been exposed  to  the  toxins by  short‐term exposure via dialysis. In this outbreak of acute liver failure 116 of 131 patients experienced adverse effects of exposure, 100 developed acute liver failure and 76 of them died. The evidence for MC exposure has been shown with number of samples that had been  taken  from  the  patients  receiving  the  contaminated  water  through  renal dialysis  and  the  concentrations  of  MCs  in  liver  and  serum  tissues  have  been reported  [49,  119‐121].  The  serum  concentrations  varied  between  patiences,  in the  range  of  7‐31  ng/ml  serum  [122]  and  50‐472  ng/g  of  fresh weight  in  livers [119].    1.3.2.4. Plants  Contamination  of  plants  by  MCs  have  been  studied  e.g.  in  [37,  123‐124]. Contamination  occurs  usually  by  irrigating  the  plants  with  contaminated  water. The accumulation of these toxins into plants constitute a hazard of toxins in food in the  same way  as  by  contaminated  fish, mussels  or  crabs.  Furthermore MCs may affect  the crop size. Plant protein phosphatases are susceptible to damage by MC exposure  [92,  125].  In  plants  these  proteins  regulate  essential  functions  such  as ion channel activity, carbon and nitrogen metabolism and gene expression as well as  growth  and  developmental  processes  (reviewed  in  [126]).  The  negative alleopathic effect of MC‐LR on aquatic plants (macrophytes) was shown in [127], starting from concentrations as low as 1µg/l. In general the exposure studies have been  performed  with  very  high  concentrations  of  MCs,  higher  than  naturally relevant. However, the species –specific sensitivity to MCs would suggest that the overall alleopathich effect of MCs to higher plants would not be important, or that plants  have  developed  means  to  overcome  and  protect  themselves  from  MC exposure (reviewed in [126]). Quantitative studies on MC accumulation into plant material show low (1‐2.6 ng/g fresh weight; [37]) to up to 650 ng/g fresh weight [128]  amounts  of MCs  to  accumulate  into  terrestrial  plant materials  via  normal exposure routes (irrigating) and higher amounts (up to 110 µg/g fresh weight) in aquatic plants ([129]; reviewed in [126]).    1.3.2.5.  Covalently bound toxins  There  are  not  many  studies  concerning  the  covalently  bound  MCs  in  tissues. However,  it  has  been  shown  that  the MCs  covalently  bind  to  the  target  proteins [84]. Accumulation has been shown to occur in vivo by a MMPB method [130‐132] as  well  as  by  radiolabelled MCs  [133].  Recently,  the  covalent  accumulation  was proven by histopathology analysis of aquatic snail tissues [134].  MCs are oxidised with 2‐methyl‐3‐methoxy‐4‐phenylbutyric acid (MMPB) method [135]  to  carboxylic  acid MMPB  to  assess  the  total  amount  of MCs  in  tissue.  The MMPB is formed from the characteristic Adda amino acid (Figure 1.6, formation of MMPB  from  MCs).  The  otherwise  inaccessible  covalently  bound  MCs  can  be determined  in  this  way.  MMPB  has  been  utilised  for  the  detection  total  MC concentrations  in cyanobacterial blooms [135], sediments  [136], and tissues (e.g. [130‐131, 137]). 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Lake soils and sediments have been considered a difficult matrix for MC and Nod extraction  [136],  but  in  a  study  by  Chen  et  al.  [138]  acidic  EDTA‐sodium pyrophosphate  solution  was  found  to  give  good  yield,  about  90%  efficiency  in toxin  extraction  from  lake  soils  and  sediment  samples.  Before  this,  due  to  the difficulties  in  extracting MCs  and Nods  from  the  sample,  the MMPB method was utilised for the analysis of MCs in soils and sediments [136].   










































  1.4. Risk assessment for human health  Cyanobacteria are not regarded as waterborne pathogens in the safety assessment concerning production of drinking water, since they are unable to colonise, invade and  grow  in  human  and  animal  hosts  [45].  However,  cyanobacteria  do  produce variety of bioactive compounds, which may develop hazard to human health when present  in  water  bodies.  Many  of  the  bioactive  compounds  are  peptides  with enzyme inhibition activities in e.g. mammalian cells. Some of the compounds have potential  pharmaceutical  use  but  many  of  the  bioactive  compounds  are  potent toxins in mammals and/or aquatic organisms.   There is much qualitative evidence of cause and effect  for MCs and Nods, but the data  has  been  inadequate  to  establish  a  clear  dose‐response  relationship  for human  risk  assessment.  However,  for  the  estimation  of  health  hazard,  following aspects should be taken under consideration:  The total risk of a certain toxin is evaluated on the basis of following aspects:  ‐  toxic properties of the substance,  ‐  dose responses,  ‐  possible routes for human exposure and  ‐  prevalence and concentrations of the toxin.   1.4.1. Toxic properties   (see also section 1.3., table 1.3) As reported in literature, (see review [45]) problems caused by cyanobacteria are encountered  around  the  world  and  problems  related  to  safe  drinking  water production  are  common. Human health  effects  from  cyanobacterial  toxicosis  are diverse, including gastroenteritis, nausea, vomiting, fewer, flu‐like symptoms, sore throat,  blistered  mouth,  ear‐  and  eye  irritation,  rashes,  abdominal  pain,  visual disturbance, kidney and liver damage etc [45]. As an example of the effects of long‐term  exposure,  the  cancer  incidence  rate  in  general  in  China  is  half  of  that  in Australia, but  the  incidence rate  for primary  liver cancer  is about  ten  fold higher [117]. Furthermore,  the  liver  cancer  incidence  rate  in people Qidong province of China, is more than ten fold in people drinking pond water (where cyanobacteria may  occur)  as  compared  to  people  drinking  deep  well  water  [139].  Many cyanotoxins are persistent and they are capable of bioaccumulation [99].    The  cyclic  peptide  toxins  microcystins  are  hepatotoxins  and  tumour  promoters produced  by  freshwater  cyanobacteria,  including  genera  Microcystis,  Anabaena and  Planktothrix,  which  commonly  form  mass  occurrences  in  eutrophic  surface waters. The presence of MCs in drinking and bathing waters has been recognized as  a  human  health  hazard  by  the  World  Health  Organization  and  a  provisional guideline level  for MC‐LR equivalents  in drinking water has been introduced at 1 µg/l  [116].  It  is  already  known  that  acute  exposure  to  high  MC  concentrations causes  liver  damage  [49].  Chronic  exposure  is  believed  to  promote  liver  tumour formation  [52],  and  MCs  are  risk  factors  in  the  development  of  liver  cancer. Nodularin is not only hepatotoxic and tumour promoter, but also direct carcinogen 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[140].  The  Baltic  Sea  cyanobacterium  Nodularia  spumigena  contains  practically always Nod‐R which bioaccumulates into Baltic Sea biota.  In the total risk assessment concerning toxic cyanobacteria and human health one needs to consider the possibility of multiple toxin producer genera and toxins. The assessment  of  safe  concentrations  of  a  toxin  in  drinking  water  is  not straightforward:  the  toxins  within  a  natural  bloom  extract  better  simulate  the natural exposure route for these toxins than purified toxins, but the synenergism from other compounds, or therefore the effect of the toxins themselves cannot be assessed  [99].  In  the  assessment  of  long‐term  exposure  effect  of cylindrospermopsin  Humpage  and  Falconer  [141]  found  some  differences  when administrating an extract or purified toxin to Swiss albino mice. A natural bloom sample  may  be  constituted  of  various  bioactive  compounds,  depending  on  the genera  and  taxa  of  the  cyanobacteria  in  the  sample,  growth  environment,  etc. Therefore the bloom sample might not be comparable to clean toxins, or to other type of bloom materials.   1.4.2. Dose responses  Detailed  information  on  the  exposure  to  cyanobacteria  and  their  toxins (concentrations)  are  almost  always  lacking  in  the  reported  human  illness  and death  cases.  Therefore  health  hazard  assessment  relies  on  studies  done  on animals,  and  dose‐effect  relationship  requires  some  extrapolation.  The  World Health Organization  recommendation  is max.  1  µg  of MC‐LR/l  in  drinking water [116].  The  WHO  provisional  guideline  value  of  1  μg/l  of  MC‐LR  is  derived  from information on two separate studies with 1) mice [142] and 2) with pigs [117]. The study on mice was performed for 90 days with pure MC‐LR by gavage [143]. In the study on pigs, the toxicological assessment of the study was well planned. The total concentration of MCs in the extract the pigs were exposed to, was determined with mouse  bioassay,  ELISA  assessment  and  protein  phosphatase  inhibition  assay,  all giving different values. In the HPLC analysis, it was said that none of the peaks in the chromatogram correspond to the standards of MC‐LR or MC‐RR, and that the major  peak  was  tentatively  identified  as  MC‐YR.  All  of  the  different  methods supported the conclusion that  the toxicity  to pigs was due to hepatotoxins  in  the sample, but  the existence of other possible  toxins was not ruled out. Uncertainty factors were  used  to  determine  a  guideline  value  for  the most  potent  and  best‐studied variant of the hepatotoxins, MC‐LR [117].   The WHO guideline value has been derived based on a no‐observed‐adverse‐effect‐level  (NOAEL)  for  mice  and  pigs,  40  μg/kg  body  weight  of  MCs,  utilising uncertainty  factor  of  10  for  1)  inter‐species  extrapolation,  2)  intra‐species variation and 3)  less‐than‐lifetime‐exposure,  together adding up  to a uncertainty factor of 1000. The calculations are made with following assumptions: adult body weight of 60 kg, drinking water consumption of 2 l daily, and an allocation factor for  the  exposure  to  be  mainly  from  drinking  water  0.8  [144].  The  relevance  of WHO´s guideline value to a long‐term exposure in humans has been criticised, as it has been based on studies on pigs for only 44 days. In China, where the problem of 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liver cancer and other related diseases is public concern, researchers Ueno and co‐workers  [52]  suggest  the  recommendation  for  safe  drinking  water  (taking  into account  long  term  exposure)  to  be  lowered  to  a  value  under  0.013  μg/l  of MCs. Ibelings and Chorus suggest that the allocation factor of 0.8 for drinking water  is overestimated  considering  the  possible  high  amount  of  toxin  exposure  resulting from contaminated food (mussels, prawns, fish etc. caught from the contaminated water bodies) [99].   A  similar guideline value as  for  the MC‐LR, of 1 μg/l  for  cylindrospermopsin has been proposed by Humpage and Falconer, based on a study on Swiss albino mice for 10‐11 weeks [141].    1.4.3. Possible routes of human exposure   Possible  routes  of  human  exposure  to  cyanobacterial  toxins  include  drinking  or recreational water,  contaminated  food  (e.g.  shellfish,  fish,  and  plants)  or  dietary supplements [104]; inhalation of contaminated water during showering and sauna or  recreational  use  of  water  bodies,  as  well  as  skin  contact  during  the  same activities [145]. It is of importance to notice that not all drinking water treatment processes (e.g. boiling) are efficient in removing cyanobacterial toxins such as MCs from  water.  Activated  carbon,  ozone  or  reverse  osmosis  treatment  is  required [146]. The MCs and Nods are intracellular toxins, and the greatest toxin concentrations in water occur during cyanobacterial cell lysis, in example during bloom clearance by e.g.  chemical agents,  such as  copper  sulphate. Some of  the  reported  (short  term) human  exposure  incidences  can directly  be  linked  to  bloom  clearance  actions  in drinking water reservoirs (reviewed in [147]). The accumulation concentrations  in animal  tissues are  reviewed  in  section 1.3.2. Ibelings  and  Chorus  [99]  have  reviewed  the  possibility  of MC  exposure  through contaminated aquatic animals used as food, such as mussels, fish and prawns, and found  that  the  tolerable  daily  intake  value  provided  by  the WHO  is  exceeded  in many  scenarios,  both  for  the  long‐term  as  well  as  for  the  short‐term  exposure. They  have  compiled  a  table  of  reported  toxin  concentrations  on  several  aquatic animals  used  as  food  [99].  They  also  calculated  the  relation  of  the  possible exposure  to  the  toxins  by  this  contaminated  food  and  the  tolerable  daily  intake value  for  lifetime daily exposure. The amount of  toxins reported  in  the  literature for different tissues resulted in a relation of  ‐ in fish from 0.03 up to 42.1,  ‐ in mussels from 0.3 up to 23.5, and  ‐ in crayfish and shrimp from 0.05 up to 14.3  times  the  tolerable  daily  intake  value  for  an  adult  weighing  60‐70  kg  [99].  The accumulation  of  toxins  from  water  sources  into  mussels  and  snails  and  from thereon  to  edible  parts  should  therefore  be  taken  into  account when  calculating total exposure to MCs.   As  the  cyanobacteria  cause  adverse  effects  also during  recreational  use of water bodies, visibly contaminated water bodies should be avoided, whether toxicity has been proven or not [45].     
  47 
1.4.4. Prevalence and concentrations of peptide hepatotoxins  Hepatotoxin producing cyanobacteria have been reported from all  the continents of  the world (including Antarctica  [148]). The blooms are often seasonal, usually having their peak in the warm summer months [55]. However,  long‐term blooms that  may  cause  continuous  long‐term  exposure  can  be  considered  even  more hazardous  to  human  health.  Throughout  the  year  lasting  blooms  have  been reported from warm countries such as Brazil [149] and India [68]. Eleven different cyclic  MCs  and  additional  linear  peptides  were  reported  from  a  single  bloom sample  by  Namikoshi  and  co‐workers  [150].  The  versatility  of  MC  variants  in blooms makes the toxicity assessment more intricate.  The  most  harmful  group  of  toxins  as  possible  health  hazard  to  humans  is considered  to  be  the  cyclic  peptide  hepatotoxins  MCs  and  Nods.  They  are especially  of  concern  because  they  are  not  easily  degraded:  the  toxins  remain intact  even  after  boiling.  The  other,  nonpeptidic,  toxins,  such  as  the  neurotoxic anatoxin‐a,  anatoxins‐a(S) and saxitoxins do not  remain  in  the water  for as  long, but  are  degraded  e.g.  by  sunlight  [55].  Cylindrospermopsins  are  described  to  be relatively  stable  toxins  [55].  Furthermore  the  cyclic  peptide  toxins  are  found  in animal and plant tissues as well as drinking and recreational water, and therefore multiple possible exposure routes exist.    1.4.5. Examples of reported incidents of cyanotoxins exposure  Caruaru  dialysis  center  incident  that  claimed  the  lives  of  76  people  due  to exposure to cyanotoxins through renal infusion is the best‐studied case of human exposure  to  cyanotoxins  [119,  121,  151].  New  information  on  the  long‐term exposure to MCs has been provided by the study by Chen and co‐workers [118]. In the  incidents  described  in  section  1.3.2.3,  the  tissue  samples  were  verified  to contain MCs, and  the concentrations had been determined by methods available. However,  several  incidents,  where  MC  exposure  has  been  shown  or  presumed, have  been  reported,  although  no  tissues  were  analysed  to  verify  MC contamination.   In a Brasilian incident in 1988 affecting about 2000 persons, of which 88 died, the cause for toxicosis was with great propability determined to be toxicosis from MCs via drinking water [48]. Blood and fecal samples as well as samples from drinking water  were  subjected  to  virologic,  bacteriologic,  toxicologic  and  heavy  metal analysis,  and  the  cause  was  concluded  to  be  compounds  produced  by cyanobacteria. However,  the  analytical  possibilities  for  verification of MCs  in  the samples did not exist [48].   In Palm Island in Australia in 1979 150 people required medical attention after a heavy  bloom  in  a  drinking  water  reservoir  [50,  51].  The  bloom  had  been terminated  with  copper  sulphate  and  the  hospitalisations  started  to  occur  the following  week.  The  causative  agent  was  not  identified  with  certainty,  but  the effects  differ  from  the  ones  reported  for MC  exposure,  and  cylindrospermopsins have been suggested to have been responsible [152]. 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In Armidale, Australia,  in 1981 water reservoir  that was used  for drinking water supply  was  treated  with  copper  sulphate  to  terminate  a  heavy  cyanobacterial bloom causing bad taste and odour. The population receiving the water from this reservoir  and a population  in  the  same area  receiving  their drinking water  from another source, were screened for liver function indicators in plasma samples. The sampling occurred in time periods of six weeks, before, during, and after the bloom termination.  The  samples  of  individuals  receiving  their  drinking water  from  the contaminated  water  supply  showed  significant  increase  in  gamma  glutamyl transferase  during  the  bloom  and  its  termination,  indicating  substantial  liver damage [153] (reviewed in [147]).  In  a  very  interesting  case  gastroenteritis  that  occurred  in  southern  Sweden, drinking water  line  had  been  by  accident  connected  to  an  untreated  lake water line.  Of  the  people  using  the water,  the  people  drinking  only  coffee made  of  the water  did  not  become  ill  (the  water  filtrated  through  the  ground  coffee  beans) whereas people drinking  tea  (with  the boiled water  only  flavoured with dipping the  tea  bag  inside)  did  become  ill  [53].  This  shows  how  the  MCs  (produced  by 
Plankttothrix agardhii) are not degraded even by boiling the contaminated water [53]. In  [147]  cases  of  exposure  to  cyanobacterial  toxins  by  recreational  use  of water bodies  have  been  reviewed  by  Kuiper‐Goodman  and  co‐workers.  The  exposures were  described  to  have  happened  by  swimming  and  by  canoeing  (with  eskimo‐rolls).  The  effects  of  MC  exposure  have  been  described  in  general  as  nausea, vomiting, diarrhoea,  irritation of skin and eyes, and  in two cases pneumonia that required intensive care in a hospital [54].  Human risk assessment is still hampered by the lack of knowledge, and by the lack of specific detection methods that would be suitable for multiple types of matrices. A clear dose‐response relationship has not been determined for humans. 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 1.5.  Methods  and  sample  preparation  for  quantitative  analysis  of cyanobacterial peptide hepatotoxins  Cyanobacteria appear in many different cell forms and structures. It is impossible to determine the toxicity of the strain by just looking at its appearance. Therefore methods  for  toxicity  determination  are  required.  The  success  of  any  analysis  is dependent  on  the  sample  treatment  performed.  In  an  inter‐laboratory  study participated  by  31  laboratories  from  13  countries  it was  found  that  the  various laboratory methods  for detection and sample preparation of MCs and Nods gave satisfactory  precision  on  cyanobacterial  bloom  field  sample  analysis.  However, standardisation of methodologies would be required for comparable results [154].   1.5.1. Sample preparation for microcystin and nodularin analysis  The  success  of  any  analysis  is  highly  dependent  on  the  ability  of  the  sample preparation to extract the toxins to be analysed. For different purposes and sample types some differences in sample preparation exist. However, the main point is to concentrate  the  toxins  in  the  sample,  at  the  same  time  as  removing  some of  the disturbing sample matrix (sample clean‐up) by solid phase extraction. In  bloom  sample  analysis  the  sample  can  be  filtered,  and  the  cyanobacterial material  on  the  filter  analysed,  since  the  cyanobacterial  peptide  toxins  exist  in intact cells. The toxins become available for extraction by cell lysis. Therefore the cells need to be disrupted before extraction for example by freeze‐drying and ultra sonication. Probe sonication was  found to be best alternative  for this purpose by Rapala and co‐workers  [155]. MCs and Nods have commonly been purified  from water  and  cyanobacterial  bloom  samples  by  extraction  with  methanol:n‐buthanol:water (20:5:75) [156], but also water (with or without acidification) and different concentrations of aqueous methanol have been employed [155, 157‐159]. Fastner  and  co‐workers  found  that  for  extracting  cyanobacterial  bloom  samples 75%  aqueous  methanol  is  the  most  efficient  solvent  [160].  Sample  preparation methods  for  MC  and  Nods  have  been  reviewed  by  Smith  and  Boyer,  and  the information nicely collected into a table in [161].   Biological  tissues,  with  usually  low  levels  of  toxins  present,  are  difficult  and variable  matrices,  for  which  the  extraction  efficiencies  are  highly  dependent  on tissue  type.  Tissues  must  be  homogenised,  the  sample  structure  needs  to  be broken  down  (intricate  in  the  case  of  rigid  structures  such  as  plant  and  feather material)  and  some  additional  sample  preparation  steps  might  be  required,  for example  protein  precipitation  for  serum  samples.  Tissue  sample  preparation requires  more  efficient  concentration  of  the  sample.  Also,  sample  preparation steps  for several samples should be performed at a  time  in the  interest of saving time. For  these purposes and especially  for better overall  cleanup one nowadays uses  solid  phase  extraction  (SPE),  eg.  reversed‐phase  C‐18  material  [157],  CN  ‐material  [162]  hydrophilic‐lipophilic‐balanced  (Waters  Oasis  HLB)  cartridge material [155] and immunoaffinity SPE [163].  A  rather  new  and  still  costly  SPE method  utilises  Molecular  Imprinted  Polymer (MIP) material [164]. 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1.5.2. Detection methods   1.5.2.1. Biological tests  A  large  amount  of  the  knowledge  collected  in  the  past  about  MC  and  Nod prevalence  and  toxicity  has  been  obtained  by  mouse  bioassay.  Pathological findings have been supported by organotropism studies made with radiolabelled toxins [165]. These studies have shown that the liver is the main target of MC and Nod [79]. However, the use of mouse bioassay is no longer encouraged due to the apparent  drawbacks  of  it  being  unethical,  unspecific  and  insensitive.  The  other biological  assay  often  encountered  in  the  detection  of  MCs  is  the  brine  shrimp (Artemia  salina)  biological  assay,  but  this  method  as  well  suffers  from  being nonspecific and insensitive [98, 166].    1.5.2.2. Biochemical methods  Nucleic acid based methods  Polymerase  chain  reaction  (PCR)  has  been  used  for  cyanobacterial  detection purposes  for  microcystin  producing  strains.  The  detection  is  done  either  with general primers for the peptide and microcystin synthetases, or with more specific primers  targeting  specific  (one  or  several)  of  the  peptide  synthetase mcy  genes. The mcy genes are from a gene cluster responsible  for toxin production enzymes [167]. Quantitative PCR has  the advantage of  revealing  the main producer of  the toxins  in  a  more  complicated  mixture  of  cyanobacterial  strains  in  a  sample.  In quantitative PCR as well,  the primers used have been  targeting  specific  genes  in the peptide synthatase gene cluster mcyA, B, E, and or D [168]. DNA microarrays have recently been utilised for the analysis of environmental water samples for MC and Nod production [169]. The DNA microarray chips offer an advantage over the more traditional genetic methods by quickly producing large amounts of data in an automated fashion. The  nucleic  acid  based  tests  are  only  applicable  to  determine  the  existence  of toxic/  nontoxic  cyanobacterial  strains  in  water  samples,  not  the  toxins concentration, nor  the possibility of  toxins  in other  tissues  than those containing cyanobacterial cells and genetic material.  ELISA The most commonly used method for MC and Nod detection is most probably the ELISA (enzyme‐linked immunosorbent assay) that is based on the detection of the specific  interaction  between  antibodies  and  analytes,  in  this  case  the  MCs  and Nods.  The  antibodies  are  often  developed  against  conjugates  of  the  Adda‐amino acid  [170]  or  the  most  common  MC  variant  MC‐LR  [171‐172]  or  MC‐RR  [173]. ELISA is very sensitive detection method for water samples, but is not intended for other sample materials such as cyanobacterial bloom or animal tissues.  ELISA detection has some limitations such as the unequal cross reactivity between different  variants  of  MCs  and  Nods  that  affects  quantitation,  as  well  as  cross reactivity  with  sample  matrix  that  causes  problems  in  both  qualitative  and quantitative  analysis. The ELISA  is designed  to be used with water  samples,  and the low detection limits enable water samples directly (without concentration) to be analysed  in order  to determine whether  the WHO guideline value of 1 µg/l of 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MC‐LR has been exceeded or not. However, as the detection is based on molecular recognition and not toxicity, the different variants give different responses, but the response  difference  cannot  be  connected  to  toxicity.  On  the  other  hand,  the possible matrix effects  from different types of  tissues can be severe, especially at lower levels of toxins where the sample cannot be diluted well. Therefore, all the different  matrices  should  be  assessed  with  controls  and  spiking  studies  before drawing conclusions of levels of MC or Nod. ELISA can be done by two different methods, by direct competitive or by indirect noncompetitive way [174].   Protein phosphatase inhibition assay The protein phosphatase inhibition assay (PPIA) is based on the inhibitory potency of MCs  and Nods  towards  the  known  targets  protein phosphatases.  The  assay  is not recommended for analysis of complex tissue samples, because of the potential matrix  interference  towards protein  phosphatase  activity  (by  tissue  components or other toxins such as okadaic acid), as well as masking of  the  inhibitory effects from the MCs by the sample’s endogenous phosphatase activity [155].  The  PPIA  can  have  colorimetric  detection  (utilising  dephosphorylation  of  p‐nitrophenyl phosphate) or radioactively  labelled  32P, or by competitively binding to (125I)MC‐YR [174].  Both of the above‐mentioned assays, ELISA and PPIA, are group‐selective methods, and therefore the different variants cannot be separately identified and quantified. Furthermore  the  response  for  these  analyses  by  the  different  variants may  vary significantly, and also cross‐reactivity with the matrix may potentially cause false positive results or mask the toxins from being detected [175].   1.5.2.3. Physico‐chemical detection methods HPLC In HPLC the separation is most commonly achieved with reversed‐phase (RP) C‐18 stationary  phase  columns  [176].  Modified  RP‐columns,  such  as  the  RP‐amide column with amide functional group, has been shown to have its advantages in the separation of MCs [177]. UV‐ (e.g. DAD) detection of MCs and Nods is based on the characteristic absorbance spectra of the Adda amino acid in the structure. Trans‐conjugated diene structure in Adda is responsible for the absorbance maximum at 238 nm. The residue Mdha contributes to the spectra as well.   Traditionally,  the  column  performance  in  the  separation  of  MCs  and  Nods  have been tested by looking at some rather intricate pairs of MCs to separate, the pairs dmMC‐LR/MC‐LR,  MC‐LR/MC‐YR  and  MC‐LW/MC‐LF.  The  task  of  separating  a certain pair of MCs is not a trivial question, as the MCs have a rather wide range of hydrophobicities [178] and require a wider gradient in order for the whole range of toxins to be resolved.  The mobile phase solvents have traditionally been water‐acetonitrile, or,  in some cases water‐MeOH [179], but this has been shown to produce wider,  less  intense peaks  with  peptidic  analytes  in  general  [9].  The  pH  in  HPLC  separation  is commonly  acidic  in  order  to  protonate  the  carboxylic  groups  present  in  the analyte.  The  acid  is  commonly  either  trifluoro  acetic  acid  (low  light  absorbance and  therefore  suitable  for  UV‐detection,  but  not  suitable  for  MS  because  of  ion 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pairing)  or  formic  acid  (suitable  for MS  detection,  not  suitable  for  UV  detection because  of  strong  absorbance).  Isocratic  separation  is  still  preferred  in  some laboratories,  but  gradient  runs  have  benefits  in  separation  of  variants  with variable hydrophilicity.  The  addition  of  ammonium  acetate  may  give  advantages  in  resolving  the demethylated variants from the methylated corresponding ones, such as dmMC‐LR from MC‐LR [155].   The great number of closely related variants make the separation and detection of the  different  variants  more  complex.  Eleven  different  cyclic  MCs  and  additional related  linear peptides were  reported  from a  single bloom sample by Namikoshi and  co‐workers  [150,  180]. The  lack of  suitable  standards  causes problems with any  type  of  analysis.  The  standards  are  required  for  the  assessment  of  the compound  behaviour,  especially  in  complex matrices.  There  is  a  requirement  of standards for the HPLC analysis, since the different variants are detected based on their retention time and UV‐absorbance spectra. There are no major differences in the absorbance spectra  for many of  the variants, and therefore  the different MCs cannot  be  distinguished  based  on  the  spectra  [181].  However,  MCs  containing tyrosine (Y) or  tryptophan (W) have additional  functional groups contributing to the  absorbance  spectra  and  can  this  information  can  be  utilised  in  toxin identification [176].  Early work on HPLC MC separation was conducted by [182] and [183] and in Prof. Harada’s laboratory [157, 184]. From that time instrumentation and methods have developed  towards  faster  analysis  and  higher  throughput  [176‐177]  and  ultra high‐performance  separation with  small  particle  size  columns  has  recently  been utilised  by  several  research  groups,  by Wang  and  co‐workers  [185],  Xu  and  co‐workers [186], Ortelli and co‐workers [187], and Oerhle and co‐workers [188] as well as in our laboratory [189].  LC‐MS Complete  separation  of  the  different  toxin  variants  is  not  a  requirement  in  MS, since  the  analytes  can  be  separately  detected  by  their m/z  ratio.  No  toxin‐class specific probes are required. This also means that different toxin species even from different  toxin  classes  can  be  quantitatively  analysed  in  one  analysis.  Highly reliable  analysis of natural products with LC‐MS  is often hindered by  the  lack of suitable standards. The lack of standards is especially apparent in areas of analysis where the analyte is as complex as the MCs and Nods: most toxins, and especially the isotopically labelled ones are not currently available. The lack of suitable well‐defined standards of even the unmodified MCs have been acknowledged by many researches  [175,  190‐191].  However,  the  requirement  of  an  internal  standard  is not  plausible  to  be  fulfilled  for  each  toxin  in  a  cyanobacterial  extract.  Therefore external standards (as standards in adjunct runs) of the compounds themselves (of the ones available) should be used. LC‐MS is an established tool in MC and Nod detection in water samples [176, 192] and  in  tissues  [158],  and some structural  studies have also been conducted with MS instrumentation [65, 72, 193‐194]. 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In general the hepatotoxin detection has developed in recent years especially due to the advances in HPLC‐MS, but also in the qualitative analysis in bloom samples in the area of nucleic acid based detection methods.  MMPB –method As  described  in  section  1.3.2.5.,  the  2‐methyl‐3‐methoxy‐4‐phenylbutyric  acid (MMPB) method by  [135]  is used  for  the assessment of  the  total  amount MCs  in tissues, bloom samples and sediments (Figure 1.6 in section 1.3.2.5.,  formation of MMPB  from  MCs).  With  the  MMPB  method  also  the  otherwise  inaccessible covalently bound MCs can be determined from different tissues.   All MC variants are detected with equal intensity, since all MC variants containing Adda give rise to one MMPB molecule, i.e. not at all related to the toxicity levels of the different variants. With MMPB ‐method both the covalently and noncovalently bound toxins are detected.  The  MMPB  method  can  be  performed  with  the  Lemieux  oxidation  [135]  using oxidative  chemicals  such  as  potassium  permanganate  and  sodium  perjodate  at basic pH, or by ozonylation [195]. After the chemical reaction, oxidation, has been quenched with acid and some reducing agent, such as bisulfite and acid, the MMPB containing  sample  is  cleaned  up  by  liquid‐liquid  [131‐132,  196]  or  solid  phase extraction  (SPE)  [121,  197],  and  in  case  of  GC‐MS  analysis  derivatised  to MMPB methylester with the help of trifluoroborate before detection [136]. The MMPB is then detected with LC‐MS (or GC‐MS) system. One can use MMPB‐d3, 5‐phenyl valeric acid (5‐PP) or 4‐phenylbutyric acid (4‐PB) as  internal standards in the analysis. 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2. Aims of this study  The overall aim of this project was to develop quantitative liquid chromatography ‐ mass  spectrometry  (LC‐MS)  detection  method  for  cyanobacterial  peptide hepatotoxins present in animal tissues and biofluids. Thereon, these methods were used  to  answer  relevant  biological  questions  concerning  exposed  samples.  The exposed  samples  were  provided  by  collaborators  (Drs.  Harri  Kankaanpää,  Vesa Sipiä and Emilie Lance). The samples were used for both method development and validation  and  further  on  for  analysis  of  the  contaminated  tissues.  The  sample preparation and LC‐MS analysis were performed at instrument facilities at the Åbo Akademi  University  and  at  the  University  of  Turku  Instrument  Centre.  The  first part  of  publication  V  was  planned  and  performed  at  the  Institute  for  Marine Biosciences, National Research Council of Canada, Halifax, Canada.  The methodology used was developed further by  1) improving sample preparation 2) improving  chromatographic  separation  and  speed  with  higher  efficiency fast chromatography 3) improving MS detection methods (including  SRM transition and instrument parameter optimisation)  The  methods  used  for  the  purpose  of  tissue  analysis  included  extraction  of  the toxins, and chemical oxidation of the tissue to release the Adda‐derived fragment MMPB. The resulting extracts were analysed with LC‐MS equipment. The  sample  preparation  both  for  the  free  and  covalently  bound  toxins  was optimised  from  the  existing methods  in  our  laboratory.  In  LC‐MS  detection,  low instrument  performance  was  noticed  with  the  most  difficult  samples.  After  the introduction of new instrument technologies the existing detection methods were optimised  for  faster  and  more  accurate  analysis.  The  test  samples  were  first extracted  and  SPE‐processed  cyanobacterial  bloom  samples  (publication  IV)  and then more intricate spiked serum samples (publication V).   The MS  instrumentation used  included a QQQ, a quadrupole  ion  trap, a spherical ion  trap  and  a quadrupole‐TOF  instrument. MS  instruments  from  three different instrument manufacturers (Waters (Micromass), Bruker and Applied Biosystems) were therefore used. 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Specific aims  Publication I Assessment of nodularin concentrations in eider duck feathers, livers and in their food supply, Baltic Sea blue mussels. The methods employed were ELISA and LC‐MS.  This was  the  first  report  of  the  cyanobacterial  hepatotoxins  (this  case  toxin Nod‐R) detected in feathers with LC‐MS instrumentation. Previously MCs had been reported in feathers in one publication, the detection therein was done with HPLC and ELISA. The detection method in publication I was LC‐ESI‐MS‐MS (QQQ).  Publication II Optimisation of MMPB method  (sample preparation  and LC‐MS methodology)  to be  used  in  aquatic  snail  tissues  and  calf  serum.  The  method  assesses  the  total amount  of  microcystins,  free  form  together  with  the  covalently  bound  MCs  in tissue. The extraction procedure for free MCs for the same tissues was assessed as well. The detection method in publication II was LC‐ESI‐MS‐MS (QQQ).  Publication III Utilisation of the optimised method described in publication II  for the analysis of total, covalently bound and extractable MCs in aquatic snails exposed in naturally relevant concentrations  in  laboratory conditions. The detection method here was LC‐ESI‐MS‐MS (QQQ). Confirmatory analysis was done with ELISA.  Publication IV Analytical LC columns of different stationary phase materials were compared  for the  fast  separation of 13 variants of MCs and Nods. The purpose was  to  test  the suitability  of  fast  resolution  columns  to  the  separation  of  MCs  and  Nods.  The detection method here was LC‐ESI‐MS (spherical ion trap).   Publication V Separation  and  accurate  mass  detection  of  MCs  and  Nods  from  spiked  serum samples  by  utilising  a  small  particle  size  column  for  separation  and  an  accurate mass  spectrometer  for analyte detection. The choice of  column was partly based on  the  study  conducted  in  paper  IV  and  the  study  done  in  the  first  part  of publication  V.  The  detection  method  in  publication  V  was  LC‐ESI‐MS  (Q‐trap; column selection) and LC‐ESI‐MS‐MS (Q‐TOF; spiked serum study).   
  56 
 3. Experimental procedures 3.1. Materials  Chemicals used in the laboratory work, e.g. for the oxidation in the MMPB method, are listed in the publications. The MMPB standard is available from Wako Pure Chemical Industries, Ltd (Osaka, Japan). Solvents  and  solvent  pH  modifiers  were  of  HPLC/LC‐MS  grade  from  known suppliers. Chromatographic mobile phase was typically water (purified to 18.2 MΩ cm  (Milli‐Q)  in  a  Millipore,  Bedford,  MA,  USA  system)  and  acetonitrile  acidified with 0.1 % formic acid.  The  first  part  of  publication  V  was  conducted  with  mobile  phase  composed  of water  and  acetonitrile,  both  modified  with  50  mM  formic  acid  and  2  mM ammonium  formate  (pH  2.3).  In  second  part  of  publication  V  different  mobile phases were tested: mobile phase consisting of aqueous part modified with formic acid and with/ without ammonium formate and organic part, acetonitrile, modified with  formic  acid.  These mobile  phases were  tested  for  differences  in  separation and detection in the LC‐MS system.  Cyanobacterial  toxins  were  purified  (by  Lisa  Spoof  and  Jussi  Meriluoto)  from cultured  or  field‐collected  cyanobacterial  material.  Toxins  produced  by  strain PCC7820 have been reported to be MC‐LR, ‐LY, ‐LW and –LF [198] and from strain NIES‐107 mainly 3‐demethyl‐MC‐RR, MC‐RR, MC‐YR, 3‐demethyl‐MC‐LR and MC‐LR  (partially  reported  in  [199]). MC‐LA was purchased  from Alexis Biochemicals (Lausen, Switzerland). The Nods were purified from Baltic Sea Nodularia [158] and identified  in  accordance  with  the  fragmentation  patterns  published  by  Mazur‐Marzec and co‐workers [194].  Cyanobacterial  bloom  material  used  in  publications  II‐IV  was  collected  from Sulejow  reservoir  in  Poland  in  2002  by  Dr.  Tomasz  Jurczak,  and  identified  to contain Microcystis  aeruginosa  and M. wesenbergii  [200].  The main  toxins  in  the Sulejow material were MC‐RR, MC‐YR, MC‐LR, MC‐LA and MC‐YA. The used standard and sample mixes are described more in detail in publications.   3.2. Instrumentation The  work  described  in  publications  I‐III  were  carried  out  on  an  Agilent  1100 binary  pump  HPLC  system  (Waldbronn,  Germany)  coupled  to  a  Quattro  Micro (from Waters, Manchester, UK) QQQ MS with  an ESI  source. The  separation was achieved on a Purospher STAR RP‐18e (Merck, Darmstadt, Germany) 30 mm × 4 mm i.d. column with 3 µm particles, thermostated to 40 °C.   In  publication  IV  the  instrumentation  consisted  of  an  Agilent  Technologies (Waldbronn,  Germany)  1200  Rapid  Resolution  (RR)  LC  coupled  to  a  Bruker Daltonics (Bremen, Germany) HCT Ultra Ion Trap MS with an ESI ion source. The 1200 RR LC system included a model SL binary pump, vacuum degasser, model SL autosampler (set at 10 °C), and model SL column oven thermostated to 60 °C.  A  similar  LC  system  was  used  in  publication  V,  coupled  to  an  1)  Applied Biosystems 4000 QTRAP (Sciex, Canada, at the National Research Council, Halifax, Canada) Q‐Trap MS,  and  2) micrO‐TOF  (Bruker Daltonics,  Bremen,  Germany) Q‐TOF MS. 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In  both  studies  (IV  and  V)  multiple  columns  were  used.  The  columns  tested  in publications IV and V are listed below:  ‐ Ascentis Express from Supelco,  ‐ Fortis C‐18 from Fortis Technologies,  ‐ Zorbax RR Eclipse plus and Zorbax RR Stable Bond from Agilent Technologies,  ‐ Chromolith FastGradient from Merck,  ‐ Synergi Fusion‐RP, Hydro‐RP, MAX‐RP and Polar‐RP from Phenomenex  ‐ Waters Acquity BEH C‐18 from Waters.  Column specifications are described in detail in publications IV and V.    3.3. Methods 3.3.1.  Preparation  of  tissue  samples  for  extraction  of  toxins  from feather, liver, mussel, aquatic snail and serum samples (publications I‐III, V)  Sample homogenisation Sample  preparation  started with  a  careful  dissection  and  homogenisation  of  the sample tissue. This part was mostly performed by our collaborators according to our  instructions.  The  freeze‐dried  material  is  the  easiest  to  work  with  for quantitative analysis, since in the dry material the different water contents in the sample does not compromise comparison between different samples.   Extraction In  general  the  sample  preparation  started  with  extraction  of  the  toxin  with  or without  the  help  of  1)  probe  sonication  2)  bath  sonication  followed  by centrifugation.  The  supernatant  taken  to  analysis was  evaporated,  and/ or  some water  added  in  order  to  reduce  the  solvent  strength  before  the  sample  is introduced  to  solid  phase  extraction  (SPE)  cartridges.  In  case  of  (fresh,  i.e.  not freeze‐dried) serum, sample preparation differed from the other tissues in that the protein  precipitation  and  extraction was  combined  and  no  sonication was  used. The protein precipitation step was performed with acetonitrile acidified with TFA.  Extraction was performed as described in detail in publications I‐III, V.   3.3.2.  Preparation  of  aquatic  snail  and  serum  tissue  samples  for  the assessment  of  covalently  bound  microcystins  with  the  MMPB  method (publications II and III)  The tissue samples were treated with the following steps in the MMPB method: 1) trypsination 2) sample oxidation 3) quenching of oxidation  4) sample clean up with centrifugation and SPE 5) sample reconstitution into LC‐MS applicable solvent   The  samples  were  homogenised  and  weighed  before  protein  cleavage  by trypsination,  which was  performed  at  37°C  in  phosphate  buffer  pH  7.5,  for  two hours under shaking. 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The sample was oxidised for three hours, pH 9.0, in room temperature, with 0.1 M potassium permanganate and 0.1 M sodium perjodate. The reaction was quenched with  40%  sodium  bisulphite  and  10%  sulphuric  acid  and  the  sample  mix  then centrifuged.  The  supernatant  was  cleaned‐up  and  concentrated  by  solid  phase extraction  (Waters Oasis HLB 30 mg cartridges). The  final eluant of  the SPE was evaporated to dryness on a heat‐plate under argon flow, and the residue dissolved into  35%  MeOH  for  LC‐MS  analysis.  A  flow  chart  of  this  process  is  given  in publication II.   3.3.3. Chromatographic  separation  and MS  detection  of  the  hepatatoxins and MMPB  HPLC The  utilised  LC‐MS  instrumentation was  as  described  above  (QQQ,  Trap,  Q‐Trap and Q‐TOF) coupled to HPLC instrumentation. MCs were separated with gradients typically  with  following  conditions:  mobile  phase  consisted  of  water  and acetonitrile modified with  formic  acid with  or without  ammonium  formate.  The gradients  started  from 25%  to 35% acetonitrile  and were  risen  to 65%  to 75 % acetonitrile  before  a washing  step  from 80%  to  90% acetonitrile.  Flow  rate was typically 0.5 to 1.1 ml/min, the washing and equilibration was done with a higher flow rate  (flow directed  to  the waste) when possible. The gradient specifications are described in more detail in publications (I‐V).  MMPB was  separated with  a mobile  phase  system of  0.1% FA  in water  (A),  and AcN (B), with the following gradient: from 40% to 70% B over 3 min, increase of B to 90% B over 0.1 min, which was held for 1 min, flow rate 0.5 ml/min, followed by equilibration at 40% B for 4 min, flow rate 1 ml/min.  Mass spectrometry detection The MS parameters are described in detail in the publications. The most important parameters, the ion selection modes were:  Either  single  ion  recording  (SIR)  or  multiple  reactant  monitoring  (MRM)  mode with  the QQQ and Q‐trap.  In SIR  the monitored  ions were  commonly  [M+H]1+ or [M+2H]2+  (MC‐RR  and  dmMC‐RR).  In  the  MRM mode  the  monitored  transitions were  from  [M+H]1+ or  [M+2H]2+    to  the characteristic  fragment of m/z  135  from Adda amino acid. In both cases the monitoring occurred with a mass window of 1 Da.  MMPB  detection  was  carried  out  in  the  MRM  mode  with  the  strongest transitions from m/z 209 to m/z 91, 131 and 191;  Scanning function with scanning range from m/z 300 to 1200 was used in the ion trap instrument in order to include both the doubly and singly charged ion species;  The  detection mode with  the  Q‐TOF MS  instrument was  scanning  function with automatic MS‐MS mode with the scan range from m/z 50 to 1500. The range from lower m/z values was included in order to record the whole fragmentation pattern with the MS‐MS function. 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4. Results and discussion  The  aim  of  this  project  was  to  develop  and  optimise  LC‐MS  methods  for  the detection of cyanobacterial peptidic hepatotoxins from complex biological tissues. This goal is important for the determination of toxin exposure and contamination levels  in  different  organisms.  The  biological  tissues  studied  during  the  project, feathers and snail  tissues, were analysed  to answer relevant biological questions concerning  toxin  accumulation.  These  tissues  as  well  as  spiked  serum  samples were  used  to  develop  the methodology  further.  In  the  end,  this  knowledge may provide  tools  for  the  correct  and  accurate  assessment  of  ecological  effects  and risks to human health by these toxins.   The  results  described  here  highlight  the  main  results  presented  in  detail  in publications I‐V.    4.1. Spiking studies  During  the  project  it  became obvious  that  the  spiking  studies  play  an  important role  in  the  valid  detection  and  correct  interpretation  of  the  results.  The instruments  are  getting  better  in  separation  of  disturbing  compounds,  by  better ionisation  efficiencies  and mass  accuracies.  Therefore,  the  statistical  calculations on  matrix  effects,  of  signal  suppression  or  enhancement  will  most  probably become easier, but still should not be forgotten.  The  spiking  studies  are  essential  in  the  estimation  of  the  true  signal‐to concentration relationship in the studied complex matrices.   In  case  of  the  natural  samples,  it was  impossible  to  perform  the  relative matrix effect assessment (the difference of matrix effects between specimens of the same species [15‐16]) by spiking studies. The assessments of absolute matrix effects, i.e. matrix effect of a sample (control material) to a standard solution, were made by spiking on selected samples, controls, either on a blank sample or on sample where the toxin concentrations was determined to be below LOD. Spiking was performed  in  the beginning of  the sample  treatment procedure,  into untreated samples, and after sample clean‐up in order to estimate recovery from the extraction, as well as  to assess  the matrix effects. The samples spiked with a known concentration of MCs and Nods  in the beginning were compared with the samples  spiked with  the  same  concentration  of  the  toxins  after  clean‐up  (in  the end)  for the assessment of extraction recovery. The samples spiked in the end of the sample preparation were compared to standards without any matrix in order to  assess  the  matrix  effects.  [16].  Results  for  the  different  spiking  studies  are described below (see sections 4.3. and 4.4).     4.2. Extraction of nodularins from eider duck feathers (publication I)  Feather  matrix  was  a  laborious  tissue  type  to  handle,  due  to  the  difficulties  in homogenising the sample. The long (2×1h) extraction periods in an ultrasonication bath  were  considered  necessary  for  adequate  toxin  recovery,  but  could  not  be 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tested due to the nature of the samples. Spiking studies could not be considered as reliable  tool  for  the  determination  of  extraction  efficiency  from  the  rigid structures,  but  were  used  in  matrix  effect  determination.  The  values  for  Nod contamination were in correlation with the values determined for the liver tissue (see table 4.1). However, some differences were seen in ELISA and LC‐MS results for  the  feather  samples. The differences were most probably due  to  the  fact  that the analysed feather samples were not the exact same extracts, or even the exact same  feathers  between  the  two  analysis  methods,  although  from  the  same individual  bird.  Furthermore,  utilisation  of  two  different  types  of  analytical methods, biochemical and physicochemical,  is a source for differences in analysis performance, for example by differences in matrix disturbance.  Table 4.1. Nod  in  eider  duck  tissues,  livers  and  feathers,  as  determined  by  LC‐MS.  Confirmatory analyses were made with ELISA.  
* Concentration in liver ** Concentration in feather  The  bird  feather  tissue  analysis  may  be  regarded  comparable  to  human  hair analysis, and is of interest to a biologist assessing the toxins in the ecosystem. The feather  analysis would  be  a  non‐invasive method  for  the  survey  or  screening  of exposure levels in eider ducks. Futhermore, the eider ducks flesh is consumed by humans and the assessment of toxin,  Nod,  accumulation  into  eider  ducks  is  therefore  of  relevance  to  human health.  Nods  have  been  shown  to  exist  also  in  the  eider  duck  muscle  tissue  in minor amounts 21 ng/g [111]. The exposure levels should therefore be assessed to assure that these carcinogens are not consumed by humans.   4.3.  Extraction of free microcystins (publications II, III and V)  Sample preparation plays a crucial role in the analysis. One of the key elements is sample  homogenisation  before  further  sample  treatment.  After  the  analysis  of aquatic  snails  tissues  it  was  noticed  that  homogenisation  of  the  tissue  in  liquid with Ultra‐Turrax works well, either prior (to enable real homogenisation) or after freeze‐drying (the problem of weighing heterogeneous sample material remains). The  weighing  of  the  freeze‐dried  material  is  somewhat  difficult  at  times.  The material may adhere to the tube walls and the particle density (weight related to size) differed quite substantially between tissue pieces. As a general rule even the samples  from  the  same  tissues  of  the  same  species  may  differ  considerably 
Species   (sex)   Sample     Sampling time       LC‐MS        (µg/kg DW)        ELISA         (µg/kg DW)  Eider (male)   Liver     3th June  2005  2.7  ‐  Eider (female)  Liver, Feather   28th Aug.  2005  7.7*, 12**  48.9**  Eider (female)  Liver, Feather   28th Aug.  2005  31.7*, 18**  ‐  Eider (female)  Liver, Feather   29th Aug.  2005  11.7*, 8**  ‐  Eider (female)  Liver, Feather   29th Aug.  2005  5.6*, 15**  ‐  Eider (female)  Liver, Feather   29th Aug.  2005  4.7*, 11**  ‐  Eider (female)  Liver, Feather     3rd Sept.  2005  47.6*, 43**  52.1**  Eider (female)  Liver, Feather     9th Sept.  2005  3.4*, 16**  6.5** 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depending  on  exposure  media  or  alternative  feeding,  as  was  noticed  with  the freeze‐dried aquatic snail tissues.   The optimised extraction procedure for different tissues consisted of the following: Extraction  of  freeze‐dried  soft  tissues  of  snails,  fish  livers,  etc. with H2O: MeOH: BuOH;  75:20:5,  bath  and  probe  sonication  of  the  sample,  solid  phase  extraction with a Waters Oasis HLB 30 mg cartridge, a washing step with 20% aqueous MeOH and  elution  with  TFA‐acidified  90%  MeOH.  The  optimised  procedure  for  the extraction  of  free  MCs  from  aquatic  snail  tissues  is  presented  in  a  workflow description in publication II.  The  processing  of  the  biological  fluid,  calf  serum,  consisted  of  an  initial  protein precipitation  step  with  80%  acetonitrile  containing  0.1%  TFA,  followed  by  the evaporation of the sample to dryness in glass vials under argon flow at 40°C, and then reconstitution in water for SPE. The SPE was performed with a Waters Oasis HLB  cartridge  with  a  wash  step  with  15%  aqueous  methanol  containing  0.1  M acetic acid (HOAc) and elution with 80% methanol containing 0.1 M HOAc.  Table 4.2  Extraction efficiency from spiked serum and aquatic snail samples   Extraction efficiency / % Sample  Spiked  with  100 µL of  MC‐RR  MC‐LR  MC‐YR  Average Natural  bloom extract  100.2  86.1  87.2  91.2 Natural  bloom extract 1:10  86.7  78.9  80.9  82.2 
Serum 1 mL 
Natural  bloom extract 1:100  83.9  73.2  84.0  80.4 Natural  bloom extract 1:2  90.8  86.1  82.7  86.5 Serum 0.1 mL  Natural  bloom extract 1:20  80.8  74.0  86.3  80.3 Natural  bloom extract  78.1  76.8  77.3  77.4 Natural  bloom extract 1:10  51.0  56.8  58.5  55.4 
Snail 10 mg 
Natural  bloom extract 1:100  66.7  57.2  73.8  65.9 Average  from  different  matrices and concentrations  79.8  73.6  78.8  77.4  The  cyanobacterial  natural  bloom  extract  used  for  spiking  was  from  Sulejow  reservoir containing 0.6 μg MC‐RR, 0.6 μg MC‐LR, and 0.4 μg MC‐YR. Dilutions of this mixture (1:2, 1:10,  1:20,  1:100) were used  for  spiking  the  samples.  The  values  are  averages  from SIR and MRM measurements.  The methods  described  above  gave  good  extraction  efficiencies  on  spiked  tissue samples  (77%  on  average)  for  the  free,  extractable  toxins  (Table  4.2).  The recoveries  are  in  this  selection  best  for  the  variant MC‐RR  (up  to  100%)  but  in 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general  very  similar  (on  average  between  74%  and  80%)  for  the  different arginine‐containing MC variants. Lower concentrations have lower recoveries. The recovery  should  always  be  checked  for  each  tissue  type  separately,  since  the recoveries  are dependent  on many parameters  in  tissue,  such  as  fat  and protein content.  The concentrations of free, extractable MCs from aquatic snail tissues (determined by two methods, ELISA and LC‐MS in publication III) are given in table 4.4.   The concentrations of the extracted MCs from the exposed aquatic snail tissues in publication III were determined with two different methods, LC‐MS and ELISA. The results  correspond  to  each  other  well,  except  for  one  outlier  for  the  LC‐MS measurements  (week  3)  and  one  for  ELISA  (week  4)  (see  fig.  4.1).  The concentrations of extractable MCs show a clear trend of increase during exposure and decline during depuration periods (fig. 4.1).  The  utilisation  of  second,  confirmatory,  detection  method  is  strongly recommended  especially  in  the  case  of  low‐level  analysis  where  sample  matrix may disturb the detection. This reduces the changes of obtaining false negative or false positive results.  ELISA  and  LC‐MS  are  based  on  completely  different  analysis  principles  and therefore complete each other  in the analysis. Whereas MS is a molecular weight based tool, ELISA is a group specific tool recognising different variants of the same group  of  compounds.  However,  individual  analogues  cannot  be  distinguished.  In LC‐MS one can miss a  closely  related compound due  to  the  fact  that  the mass of that compound is not known or considered important, whereas with ELISA all the compounds having the molecular properties the antibodies are raised against will be  detected.  The  possibility  of  cross‐reactivity  with  matrix  compounds,  or  poor cross‐reactivity  with  some  variants  make  the  interpretation  of  ELISA  analysis more  difficult.  This  creates  differences  not  only  in  the  levels  of  possible  matrix disturbances (different between methods) but also  in the detection  levels. As LC‐MS  methods  have  improved,  they  have  become  the  methods  of  choice  in  many laboratories  due  to  the  ability  to  selectively  identify  and  quantify  the  different variants of the analytes. In publication I, the ELISA and LC‐MS did not correspond to each other as well as  in publication II. This may be due to several  factors. The individual  feathers  were  different  for  the  two  separate  analysis,  the  sample preparation  was  done  in  a  different  laboratory  and  the  extraction  procedure therefore  was  slightly  different.  In  publication  I  the  ELISA  was  mainly  used  as additional  confirmatory  assay,  and  not  to  support  the  concentration  values obtained by LC‐MS. 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Figure 4.1  Values  for  free, extractable MCs  in exposed aquatic  snail  tissues  (±standard errors). The white and light grey bars correspond to concentrations of MCs from aquatic snails exposed to cyanobacterial suspension P2 (containing 33 µg/l of MCs; described in table 4.4) with lettuce  and  the  black  and  deep  grey  bars  to  the  corresponding  experiments  without lettuce.  The  values  for  black  and  white  bars  have  been  obtained  with  LC‐MS measurements and the values for deep and light grey bars with ELISA.     4.4. MMPB methodology (publications II and III)  The MMPB method  is  of  relevance  to  determine  the  total,  both  free  and  bound forms of microcystins.  It was considered important to trypsinate the sample prior to oxidation because of two different  aspects:  the  toxin  in  the  (target)  protein  binding pocket  should  be readily  available  for  the oxidation process. As  the oxidation  is  dependent  on  the tissue surrounding the toxins it was considered important to make the toxins more accessible in the oxidating solution. On the other hand the sample preparation and clean up after the oxidation and quenching the oxidation processes were difficult. The  sample  clogged  the  solid phase extraction cartridges. This was  simplified by processing  the  samples by  trypsination and by  centrifuging  the  samples prior  to SPE.   The  optimised  sample  preparation  procedure  for  the  determination  of  total concentrations of MCs from aquatic snail tissues is given in a workflow description in publication II. The method includes seven steps of which one is trypsination for 2 h, one is oxidation for 3 hours, and the drying process takes additional 2‐3 hours. Therefore the whole sample preparation process is time consuming, and even the other  steps  (reaction quenching and checking  the pH,  solid phase extraction and elution) in the procedure are laborious and time consuming when handling dozens of samples at a time. 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As  found  in  the  spiking  studies  during  the  development  of  the  method,  the oxidation  recovery  remains  to be  the weak point  in  the MMPB method,  together with  the  matrix  effects  in  the  LC‐MS  detection  (see  Table  4.3).  The  oxidation process is a balance between oxidising the MCs into MMPB molecule, oxidising the matrix  surrounding  the  toxins  and  further  oxidising  the  MMPB  into  smaller products. The sample oxidation recovery is the measure of the proportion of MCs in a tissue recovered as the oxidation product MMPB. Some of the MCs in the tissue may escape oxidation and some of the formed MMPB may be further oxidised and lost.  The  oxidation  recovery,  extraction  efficiency  and  the  matrix  effects  were controlled by spiking of control samples as described above, but an additional step of  spiking  is  required  after  the  oxidation,  to  assess  the  oxidation  recovery (comparison  between  samples  spiked  in  the  beginning  and  after  oxidation).  The number  of  required  controls  makes  the  method  even  more  laborious,  but  the different recoveries must be assessed for each tissue type and oxidation treatment. The MMPB method  is  laborious  and  has  not  been  utilised  in many  publications. Even the current method reported in publication II suffers from low sensitivity.  The poor oxidation recovery accounts for up to (or over) 70% loss of MC to MMPB material, and the matrix effect ion suppression up to 84% loss in signal in the used LC‐MS  instrumentation.  The  matrix  effect  were  determined  by  control  sample material  with  a  known  amount  of  MMPB  and  comparing  the  produced  signal responses to the signal responses obtained from clean (without matrix) standard solutions.  Table 4.3 MMPB methodology recovery values Oxidation recovery, extraction efficiency and matrix signal suppression effect on signal recovery by LC‐MS detection, are given for serum and aquatic snail tissues.  Sample spiked with  Oxidation  recovery / %  Extraction efficiency / %  Matrix effects,  signal  in  spiked samples/ % Serum 1 mL        1.6 µg MC  31.6  85.6  18.4 1 mL        160 ng MC  39.5  97.2  16.3 0.1 mL     800 ng MC  28.9  70.7  34.8 0.1 mL     80 ng MC  33.9  73.0  37.3 Aquatic snail tissue 10 mg      8.8 µg MC  38.4  62.4  25.8 10 mg     1.6 µg MC  36.2  76.3  18.0 10 mg     160 ng MC  22.4  44.9  27.4  In addition to being able to determine the total concentrations of MCs, the MMPB method also benefits from being dependent only on one standard in the analysis. All  of  the  MC  and  Nod  variants  are  detected  as  MMPB.  The  production  and therefore  availability  of  an MMPB  internal  standard,  for  example  an  isotopically labelled  MMPB,  is  far  more  probable  than  production  of  multiple  isotopically labelled MC standards. 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The property of all MCs being detected as one molecule can be compared to ELISA assay, where the determination of the individual variants is not possible. However, in  MMPB  the  signal  response  is  directly  proportional  to  the  toxins  available whereas  in  ELISA  the  different  congeners  are  bound  to  the  antibodies  with different affinities and therefore give different quantitative responses.  The determined  concentrations  of  covalently  bound  toxins  (total  amount  of MCs determined  by  MMPB  method  –  extractable  amounts  of  MCs  in  aquatic  snail tissues)  are  approximately  half  of  the  total  contamination  burden  in  exposed aquatic snail  tissues (see  table 4.4). Concentrations of  toxins  from the tissues  for the initial exposure period and for the depuration period have been listed in table 4.4. Exposure media was on two separate experiments a bit different (described in table 4.4). In table 4.4 the extractable toxins have been analysed by two methods, with  ELISA  and  LC‐MS.  The  cysteine  and  glutathione  conjugates  of  MCs  were looked  for  during  LC‐MS  analysis,  but  their  concentrations  were  below  limit  of detection.  Table 4.4 Extractable and covalently bound MCs in aquatic snail tissues   Exposure with P. agardhii suspension P1 Containing 7.8 ± 2.3% of dmMC‐LR, 27.4 ± 2.6% of dmMC‐RR, 64.8 ± 3.1% of MC‐YR  
Exposure with P. agardhii  suspension P2 Containing 6.9 ± 0.8% of dmMC‐LR, 90.5 ± 0.9% of dmMC‐RR, 2.5 ± 0.4% of MC‐YR 
Sample: aquatic snails fed with: 
Free MCs (µg/g DW)  Bound MCs (µg/g DW)  % bound MCs  Free MCs (µg/g DW)  Bound MCs (µg/g DW)  % bound MCs End of 5 week treatment period Cyan5  25 ± 5.5  9.2 ± 2.7  27 ± 5.2  3.3 ± 0.5  6.6 ± 2.0  67 ± 7.4 Cyan5Lt  12 ± 1.7  2.6 ± 0.9  18 ± 4.2  3.4 ± 1.0 (only ELISA)  ‐  ‐ Cyan33  32.4 ± 5.2  38 ± 7.9  54 ± 7.1  4.0 ± 1.1  5.1 ± 2.5  56 ± 8.0 Cyan33Lt  ‐  ‐  ‐  5.6 ± 1.0  3.9 ± 1.0  41 ± 5.6 End of 3 week depuration period Cyan5  1.9 ± 0.3 (only ELISA)  ‐  ‐  0.3 ± 0.1  < LOD  ‐ Cyan5Lt  0.9 ± 1.2  1.7 ± 0.2  65 ± 9.3  0.2 ± 0.04  < LOD  ‐ Cyan33  5.3 ± 2.0  15 ± 5.2  74 ± 14  0.5 ± 0.2  5.1± 0.7  91 ± 7.6 Cyan33Lt  ‐  ‐  ‐  0.6 ± 0.2  4.7 ± 0.6  89 ± 4.2   Snails  were  kept  in  two  P.  agardhii  suspensions  with  different  percentages  of  toxins dmMC‐LR,  dmMC‐RR  and  MC‐YR  produced.  Both  suspensions  were  of  a  total concentration of 5 µg MC‐LReq/l without additional  feeding (Cyan5) and with  lettuce ad libitum  (Cyan5Lt);  or  of  a  total  concentration  of  33  µg  MC‐LR  eq/l  without  additional feeding (Cyan33) and with lettuce ad libitum (Cyan33Lt). Four snail bodies per treatment were mixed and 4 measures per mix were assessed using LC‐ MS and ELISA methods for free MCs assessment and using the MMPB method and LC‐MS for total (free + bound) MC assessment.  Bound  concentrations  obtained  by  calculating  [Bound  MCs  =  total  (MMPB)  MCs  ‐  free (extracted) MCs]. 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The results from the study presented in publication III show that the percentage of covalently bound toxins is not the same all the time: the trend appears to be such that  the  covalently bound  toxins  are present  in higher proportions  in  the  longer exposed  snails  and  after  depuration,  as  compared  to  the  proportions  of  the covalent bound toxins in the beginning of the exposure (see table 4.4 and fig. 4.2). Figure 4.2 describes  the  trend of proportion of  the covalently bound MCs during exposure and depuration periods.  Due  to  the  high  amounts  of  covalently  bound  MCs  in  the  tissues  of  Lymnaea 
stagnalis found in publication III it seems unlikely that the only target for covalent binding in the tissue would the protein phosphatases. Up to 37 μg/g of covalently bound  toxins  were  found.  The  percentages  of  covalently  bound  toxins,  as compared to extractable toxin amounts, are comparable to values found by others [130,  133,  137].  If  all  of  the  covalently  bound  toxins would  be  bound  to  protein phosphatases  (for  example  the  PP2A,  either  a  dimer  ~101kDa  or  a  trimer approximately  155‐173  kDa,  see  [201];  one  binding  site  per  phosphatase)  the amount of covalently inhibited protein phosphatases in the tissue would be 3.7 mg – 6.4 mg/g, which is unrealistic. Imanishi and Harada presented a study to reveal proteins  binding  to  MCs  by  a  proteomics  method  [95]  combined  with  affinity chromatography  [202‐203]  to  fish  out  proteins  binding  to  MCs.  This  kind  of experimental set‐up could be useful in finding out other possible counterparts for MC binding in different tissues. However, in that study the MCs were bound to the resin  by  the  double  bond  in  the  (Mdha)  structure,  which  could  be  crucial  for interactions with some of the target proteins.  
 Figure 4.2 The  proportion  of  covalently  bound  toxins  in  aquatic  snails  (in  percentages  of  the  total amount of MCs detected, ±standard errors). The data points marked with squares describe the  values  from  exposure  experiments  conducted  with  cyanobacterial  suspension  P2 (containing  33  µg/l  of  MCs;  described  in  table  4.4.)  with  lettuce  and  the  data  points marked with diamonds in a similar setup without lettuce. 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Aquatic snail tissues might not be considered as relevant to human health by direct exposure,  but  they  are  interesting  study  organisms  due  to  the  fact  that  they directly  consume  cyanobacteria  and  are  therefore  possibly  exposed  to  high amounts  of  toxins.  Aquatic  snails  are  consumed  by  higher  organisms  in  the ecosystem. Therefore the detection of toxins from snails is important considering studies of toxin transfer to the following trophic level.   The toxicity or the availability of the covalently bound MCs (studied in publication III) to the next trophic level is unclear [104], and this aspect can only be studied if useful  methods  for  the  determination  of  the  covalently  bound  toxins  exist.  In publication  III  it  was  found  that  approximately  half  of  the  MCs  in  tissues  are covalently bound. During depuration  (in nature  corresponding  to bloom ending) the  proportion  of  covalently  bound  toxins  increases,  probably  due  to  quicker elimination of the free MCs from the tissues as well as more MCs being covalently bound. The implications not only to the organisms exposed to MCs, but also to the next trophic level, warrant this method to be used in further studies.   The  snail  tissues are very  complex  sample matrix,  and  it  is  therefore anticipated that the methods developed for the snail tissues would be adequate for other types complex biological tissue analysis, such as analysis of liver tissues.     4.5. Chromatographic development of the LC‐MS analysis  Recent  instrument  developments  have  driven  LC‐MS  forward  in  the  aspects  of speed, detection limits, accuracy and certainty in identification. In my research two of the publications (IV and V) concern the utilisation of small particle size columns. I have  taken advantage of  the new abilities of  the  instrumentation available,  and optimised the detection to be performed in fast and accurate manner.  The following aspects were considered important in the chromatographic method development: ‐ Higher performance pumps to be able to utilise smaller particle size columns. The benefits of the smaller particle size columns have been described before. ‐ Fast autosamplers that enable the run times to be shortened, as the difference to the older systems is 4‐5 fold. ‐ Higher column temperatures have been found beneficial in RP separations due to more efficient partitioning between  the mobile  and  stationary phases  [204‐205]. In our study in publication IV, with high flow rates, the columns were kept at 60°C, which is generally regarded as the highest recommended column temperature for silica‐based  stationary  phase.  The  robustness  of  these  columns  at  the  elevated temperature was not systematically tested in this study, but the performance was stable for more than 1000 injections per column in [206]. In  general,  better  performance  is  now  easily  achievable  with  modern instrumentation and columns.  The current technologies enabled the reduction in sample analysis time for water and cyanobacterial samples to 3 min 15 s in publication IV (high throughput, with a high flow rate up to 1 ml/min) and to 8.5 min for serum samples in publication V (ion source limited the flow rate to 0.5 ml/min). 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 4.5.1. Comparison of HPLC columns in the separation of microcystins and nodularins within extracted bloom samples (publication IV)  Chromatograms Fig. 4.3  shows chromatograms of  four  columns, Ascentis Express,  Zorbax Eclipse plus,  Chromolith  FastGradient  and  Synergi  Fusion‐RP,  all  representing  different column technologies and manufacturers with 1 min gradient, total analysis time of 3 min and 15 s (including equilibration and injection) for the separation of 13 MC and Nod variants.  The mobile  phase  consisted  of water  and  acetonitrile  both  acidified with  formic acid, the gradient rise was from 25 % acetonitrile to 75% acetonitrile over 1 min. The flow was adjusted according to column inner diameter (I.D.), 1 ml/min for the 2 mm I.D. columns and 1.102 ml/min for the 2.1 mm I.D. columns. Columns were thermostated to 60°C. 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Figure 4.3  Extracted ion chromatograms produced by four different LC columns for the separation of 13 MCs and Nods in a standard mix. The whole run time per sample was 3 min 15 s from injection  to  injection.  The  mobile  phase  used  here  was  water‐acetonitrile  based,  pH modified with formic acid, from 25% to 75% acetonitrile over 1 min. 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 4.5.2. Chromatographic  performance  in  publication  V  –  column comparison and spiked serum sample study  The  tested  mobile  phase  in  the  first  part  of  publication  V,  column  comparison study, was ammonium  formate‐formic acid –based and  tested with  two different flow  rates.  Interestingly,  a  slower  (less  steep  gradient),  did  not  provide  better resolution with  these  fast  separation  columns  in  the  first  part  of  the  study with extracted bloom material. The calculated Rs ‐values were approximately the same between the 30 min (10%‐80% B) and the 5 min (30%‐75% B) gradients, or even slightly better with the 5 min gradient (see table 4.6). In table 4.6 the values that represent the best ones obtained in particular test are boldfaced. In publication V, the standard mix of 9 MC and Nod variants differed slightly (fewer toxins, did not include  linear  Nod,  dmNod‐R,  dmMC‐YR  or  MC‐LA)  from  the  one  used  in publication IV.   The Phenomenex Synergi Hydro‐RP column was chosen from the first part of the study  in  publication  V  for  the  separation  of MCs  and Nod  in  serum matrix.  This column worked well,  i.e. there was no clogging, increased backpressures or shifts in retention times even with the more complex serum sample matrix. The column was  tested  with  mobile  phase  containing  either  both,  ammonium  formate  and formic  acid,  or  only  formic  acid.  The  two  mobile  phases  performed  somewhat differently  (see  figure  4.4).  The  ammonium  formate‐formic  acid  based  mobile phase separated the chromatographically very similar compounds dmMC‐LR / MC‐LR, whereas the formic acid based mobile phase was not able to do so when using the Hydro‐RP column.   The  spiked  serum  samples  were  analysed  in  the  following  chromatographic conditions:  the mobile phase water (A) and acetonitrile  (B), either modified only with  formic  acid  or  with  formic  acid  plus  ammonium  formate  (chromatograms presented in figure 4.4). The flow rate was set to 0.5 ml/min, which is the highest flow  rate  recommended  for  the  MS  ionsource  in  the  Q‐TOF  instrument.  The gradient was as follows: 28% B to 38 % B over 3.5 min, up to 75% B over 0.2 min hold 75% B for 0.9 min. 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Table  4.6.  Some  chromatographic  performance  parameters  for  the  columns  tested  in publication V, with long (30 min), 5 min, and short (1.1 min) gradient separation, based on ammonium formate + formic acid containing mobile phase.  The best values for every assessment (per gradient) are boldfaced.  Column  Resolution  Capacity factor  Selectivity a   dmMC‐LR / MC‐LR  MC‐YR / MC‐LR  MC‐LW / MC‐LF  dmMC‐RR  MC‐LF  MC‐LF / dmMC‐RR Long gradient: from 10 to 80% of solvent B over 30 min Waters Acquity BEH C‐18  1.3  2.7  2.8  19.6  33.1  1.7 Phenomenex Hydro‐RP   0.1  2.0  2.9  19.7  39.8  2.0 Phenomenex Fusion‐RP  0.1  1.9  1.8  18.5  38.5  2.1 Phenomenex Max‐RP  0.1  1.9  2.7  19.3  38.0  2.0 Agilent Zorbax RR  0.6  3.1  2.8  20.6  35.6  1.7 5 min gradient: from 30 to 75% of solvent B over 5 min Waters Acquity BEH C‐18  1.3  2.7  1.4  3.7  13.5  3.6 Phenomenex Hydro‐RP   0.3  2.9  2.0  2.4  16.6  7.0 Phenomenex Fusion‐RP  0.0  2.8  1.5  2.3  16.1  7.1 Phenomenex Max‐RP  0.1  2.9  1.7  2.4  16.0  6.7 Agilent Zorbax RR  0.6  3.1  1.4  4.2  14.8  3.5 Short gradient: from 35 to 65% of solvent B over 1.1 min Waters Acquity BEH C‐18  0.7  2.1  1.5  1.6  7.5  4.6 Phenomenex Hydro‐RP   0.0  2.3  1.7  0.8  9.0  11.7  a Selectivity of the column has been calculated as the ratio of capacity factors for the last eluting compound, MC‐LF and the first eluting compound, dmMC‐RR. 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 4.6. Mass spectrometry detection used in this study  QQQ instrumentation In publications I‐III the instrument was a triple quadrupole MS instrument used in the SIM or MRM mode. The instrument performance suffered from matrix effects and  from  low sensitivity. With  the detection of MCs  the matrix effects and signal fluctuations  during  sample  series were  corrected  by  using  external  standards  in adjunct runs. The external standards were added in the sample series after every third or fifth sample.   Feather sample analysis on SIR mode (see figure 4.5) showed adequate selectivity over disturbing background signals  from matrix  to clearly detect Nod. Out of  the Nod  variants  looked  for  (dmNod‐R,  Nod‐R  and  LinNod‐R)  only  Nod‐R  was recorded  above  LOD.  The  spiking  studies  were  performed  on  feather  samples earlier determined to be negative for Nods.   
  Figure 4.5  Chromatogram of an eider feather extract. The SIR mode analysis performs well and gives a distinct peak  for Nod‐R  in  the complex  feather sample. Upper panel  shows a SIR  trace form  a  feather  sample,  the  lower  panel  chromatogram  of  Nod‐R  standard  (2  ng  on column). The chromatographic conditions described in publication.   The  results  from  QQQ MS  analysis  of  aquatic  snail  samples  (publications  II‐III), were calculated back to correspond the amounts in the beginning, and the amount of free MCs was expressed in µg of MCs/g DW tissue. The detection threshold was determined to be 0.1µg of MCs/g DW tissue for the variants MC‐RR and dmMC‐RR, 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and 0.2 µg/g of MCs  in DW tissue  for  the variants MC‐LR, dmMC‐LR and MC‐YR. During  the  sample  series  the  signal  response  fluctuated  considerably,  and  the matrix  effects  (signal  suppression  or  signal  enhancement)  and  their  effect  on signal response were found to differ depending on the MC variant. The  limits  of  quantitation  utilising  the QQQ  (in  publication  II  and  III)  for  spiked serum  samples  were  estimated  to  be  approximately  10  ng/ml  MCs  in  vial (corresponding  to  2  ng/ml  MCs  in  serum  samples),  for  the  different  arginine‐containing variants.  The  MRM  mode  of  detection  was  utilised  in  the  MMPB  analysis  for  better selectivity,  but  suffered  from  signal  suppression  effects  (table  4.3).  The  negative mode  could  have  offered  benefits  in  reducing  the  ion  suppression  with  the detection  of MMPB,  but  due  to  very  low  signal  response  in  the MS,  the  negative mode  could  not  be  used.  Furthermore,  the  compounds  considered  as  good candidates  for  internal  standards,  5‐PP  and  4‐PB,  failed  to  give  signal  response with the QQQ instrument in positive mode.  The  signal  fluctuation  and  suppression  effects  were  corrected  for  by  the  use  of external standards in both MC and Nod and MMPB analysis.   Spherical ion trap instrumentation In publication IV the instrument used was a spherical ion trap that was well suited for the fast detection of multiple masses (a mass range) This detector was coupled to the mobile phase with an ESI source which is compatible with high mobile phase flow  rate  (1  ml/min)  from  the  HPLC.  The  detection  limits  in  ion  trap instrumentation are somewhat higher than in triple quadrupole systems. However, the  fast  and  efficient  scan  rates  make  ion  traps  well  suitable  for  fast  gradient analysis. The limit of quantitation for MC‐RR was estimated to be in the range of 15 ng/ml or less in vial for MC‐RR, MC‐YR and MC‐LR.  Scanning  of wider  range  of  ions  enables  doubly  and  singly  charged  ions,  adduct ions, as well as some possible metabolites of the compounds to be detected within the  same  run.  Data‐analysis  tools  from  Bruker  offer  a  nice  possibility  for  peak picking called Dissect. This function finds signals increasing and decreasing in the same time frame and groups these ion species into one peak (compound). This is a good  tool  for determining peaks, but  also  to detect  the different  ion  species  that the  compound  of  interest  produces  in  the  ESI  source.  This  information  can  be useful  in the development of  fragmentation modes. Furthermore, the Dissect tool may  help  in  the  determination  if  a  new  peak would  be  of  a  novel  compound  of interest.  Ion  source  fragmentation  patterns  and  multiple  ion  species  for compounds may  have  similarities within  a  group  of  analytes,  and  therefore  give indications if the novel compound would belong to that group.  For molecular  identity  confirmatory  purposes  one  needs  to  select,  stabilise,  and fragment a precursor  ion, which  is more  time consuming  in an  ion  trap  than  for example in a Q‐TOF system. However, the spherical ion trap offers the possibility for MSn analysis, which can be useful especially in structure determination. The ion source in the ion trap used in publication IV was able to tolerate high flow rates of mobile phase, which is an important development considering the utilisation of the high throughput LC columns and methods. 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Figure 4.7  Spectral  components  and  fragmentation  spectra  obtained  by  the  MS  and  MS‐MS mode, respectively from spiked serum samples. *  ‐marked fragments have been identified from the literature to be indicative for MCs.   High‐resolution MS detection is available with the current instrumentation at fast (MS  only)  to  moderately  fast  (MS‐MS)  scan  rates,  which  makes  the  Q‐TOF instrumentation compatible with fast resolution LC systems.   During this study,  fast and accurate LC‐MS methods for the detection of MCs and Nods were developed. The methods are compatible with biological tissues. 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5. Conclusions  Cyanobacterial peptide hepatotoxins have ecological effects and constitute a health hazard to human populations all over the world. The exposure routes include both drinking water  and  contaminated  food, which  therefore  need  to  be  analysed  for assessment of contamination.  New  developments  in  the  field  of  LC‐MS  have  driven  the  analytical  possibilities forward. The utilisation of these new instruments and methods is of essence due to high demand in regulatory needs and requirements for higher throughput.   The  analysis  of  water,  bloom  and  food  samples  is  of  high  importance  due  to possibility of contaminated drinking water, but scientists are also more and more interested in studying exposed (animal) tissues. The tissue analysis requires more from analytical instrumentation due to the complex matrix and low levels of toxins. The advances in the LC‐MS field have answered to this need.   The biological questions that arise during a project can be answered with further development  and  optimisation  of  existing  methods  to  give  results  with  good reliability. The analysis of biological tissues with LC‐MS is possible but requires input on the level of sample preparation, LC separation and MS detection.   This  PhD  project  contributed  to  the  following  aspects  in  the  LC‐MS  analysis  of cyanobacterial peptide hepatotoxins:   Excellent  separation of 13 cyanobacterial  cyclic heptapeptides  could be achieved with total run times of 3min 15 s (including equilibration and injection) with new columns and rapid resolution HPLC and MS technologies in publication IV. Due to the  overall  excellent  performance  of  the  columns  it  is  suggested  that  the  small particle  size  columns,  which  enable  short  run  times  should  be  considered  for routine MC and Nod analysis, for example in the context of the ISO method 20179 (Water  quality  –  determination  of  microcystins  –  method  using  solid  phase extraction  and  high‐performance  liquid  chromatography  with  ultraviolet detection).  In  publication  V  the  MC  and  Nod  analysis  was  optimised  for  accurate  mass instrumentation  with  Q‐TOF  MS,  which  gave  benefits  in  both  qualitative  and quantitative analysis of difficult sample matrices.   In  addition  to  methodological  advances,  the  PhD  study  produced  quantitative information concerning toxin concentrations in biological specimens.   ‐  the  cyanobacterial  toxin  nodularin  was  with  high  certainty  detected  in  a  new matrix, eider duck feathers in publication I.  ‐ the optimised MMPB method (publication II) enabled the determination of total MC ‐contamination levels in aquatic snail tissues (publication III). 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